<html class="gs_el_sm gs_pfcs"><head><title>‪John Lunec‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.ca/citations?user=u3-iWPQAAAAJ&amp;hl=en"><meta name="description" content="‪Newcastle University‬ - ‪‪Cited by 8,476‬‬ - ‪cancer molecular biology‬"><meta property="og:description" content="‪Newcastle University‬ - ‪‪Cited by 8,476‬‬ - ‪cancer molecular biology‬"><meta property="og:title" content="John Lunec"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=u3-iWPQAAAAJ&amp;citpid=1"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"mLY5YcbLIsi1mwH99Yj4DA"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=u3-iWPQAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=u3-iWPQAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=u3-iWPQAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=u3-iWPQAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYTsIGE1Uh_GmOVX3axyiBeCRHyfH4JGv"><input type="hidden" name="user" value="u3-iWPQAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">8476</td><td class="gsc_rsb_std">2080</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">52</td><td class="gsc_rsb_std">27</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">130</td><td class="gsc_rsb_std">63</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:1282px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:1240px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">460</div><div class="gsc_g_xtl" style="top:73px;">230</div><div class="gsc_g_xtl" style="top:113px;">115</div><div class="gsc_g_xtl" style="top:33px;">345</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:1187px">1984</span><span class="gsc_g_t" style="right:1155px">1985</span><span class="gsc_g_t" style="right:1123px">1986</span><span class="gsc_g_t" style="right:1091px">1987</span><span class="gsc_g_t" style="right:1059px">1988</span><span class="gsc_g_t" style="right:1027px">1989</span><span class="gsc_g_t" style="right:995px">1990</span><span class="gsc_g_t" style="right:963px">1991</span><span class="gsc_g_t" style="right:931px">1992</span><span class="gsc_g_t" style="right:899px">1993</span><span class="gsc_g_t" style="right:867px">1994</span><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:1192px;top:151px;height:9px;z-index:38"><span class="gsc_g_al">28</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1160px;top:148px;height:12px;z-index:37"><span class="gsc_g_al">35</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1128px;top:154px;height:6px;z-index:36"><span class="gsc_g_al">19</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1096px;top:143px;height:17px;z-index:35"><span class="gsc_g_al">50</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1064px;top:151px;height:9px;z-index:34"><span class="gsc_g_al">26</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1032px;top:154px;height:6px;z-index:33"><span class="gsc_g_al">18</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1000px;top:151px;height:9px;z-index:32"><span class="gsc_g_al">27</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:968px;top:156px;height:4px;z-index:31"><span class="gsc_g_al">12</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:936px;top:153px;height:7px;z-index:30"><span class="gsc_g_al">21</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:904px;top:149px;height:11px;z-index:29"><span class="gsc_g_al">33</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:872px;top:140px;height:20px;z-index:28"><span class="gsc_g_al">59</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:135px;height:25px;z-index:27"><span class="gsc_g_al">72</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:134px;height:26px;z-index:26"><span class="gsc_g_al">75</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:134px;height:26px;z-index:25"><span class="gsc_g_al">77</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:114px;height:46px;z-index:24"><span class="gsc_g_al">133</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:106px;height:54px;z-index:23"><span class="gsc_g_al">156</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:93px;height:67px;z-index:22"><span class="gsc_g_al">194</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:100px;height:60px;z-index:21"><span class="gsc_g_al">175</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:63px;height:97px;z-index:20"><span class="gsc_g_al">281</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:55px;height:105px;z-index:19"><span class="gsc_g_al">304</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:45px;height:115px;z-index:18"><span class="gsc_g_al">332</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:32px;height:128px;z-index:17"><span class="gsc_g_al">369</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:38px;height:122px;z-index:16"><span class="gsc_g_al">353</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:52px;height:108px;z-index:15"><span class="gsc_g_al">313</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:26px;height:134px;z-index:14"><span class="gsc_g_al">388</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:32px;height:128px;z-index:13"><span class="gsc_g_al">369</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:34px;height:126px;z-index:12"><span class="gsc_g_al">365</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:17px;height:143px;z-index:11"><span class="gsc_g_al">412</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:6px;height:154px;z-index:10"><span class="gsc_g_al">445</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:13px;height:147px;z-index:9"><span class="gsc_g_al">423</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:36px;height:124px;z-index:8"><span class="gsc_g_al">358</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:32px;height:128px;z-index:7"><span class="gsc_g_al">370</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:32px;height:128px;z-index:6"><span class="gsc_g_al">368</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:31px;height:129px;z-index:5"><span class="gsc_g_al">372</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:40px;height:120px;z-index:4"><span class="gsc_g_al">347</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:43px;height:117px;z-index:3"><span class="gsc_g_al">338</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:27px;height:133px;z-index:2"><span class="gsc_g_al">384</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:67px;height:93px;z-index:1"><span class="gsc_g_al">269</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=u3-iWPQAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3du3-iWPQAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>30 articles</span></div><div class="gsc_rsb_m_na"><div>5 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:14%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:80pt;}}</style><img alt="John Lunec" sizes="print 80px,128px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=u3-iWPQAAAAJ&amp;citpid=1" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=u3-iWPQAAAAJ&amp;citpid=1 128w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=u3-iWPQAAAAJ&amp;citpid=1 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">John Lunec</div><div class="gsc_prf_il"><a href="/citations?view_op=view_org&amp;hl=en&amp;org=7687019144636890226" class="gsc_prf_ila">Newcastle University</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at ncl.ac.uk - <a href="https://www.ncl.ac.uk/medical-sciences/people/profile/johnlunec.html" rel="nofollow" class="gsc_prf_ila">Homepage</a></div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:cancer_molecular_biology" class="gsc_prf_inta gs_ibl">cancer molecular biology</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=u3-iWPQAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYTsIGE1Uh_GmOVX3axyiBeCRHyfH4JGv"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=u3-iWPQAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=u3-iWPQAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=u3-iWPQAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=u3-iWPQAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=u3-iWPQAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism</a><div class="gs_gray">GJ Peters, HHJ Backus, S Freemantle, B Van Triest, G Codacci-Pisanelli, ...</div><div class="gs_gray">Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1587 (2-3&nbsp;…<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7639128385667194542" class="gsc_a_ac gs_ibl">411</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer</a><div class="gs_gray">I Sigalas, AH Calvert, JJ Anderson, DE Neal, J Lunec</div><div class="gs_gray">Nature medicine 2 (8), 912-917<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5299626507989687394" class="gsc_a_ac gs_ibl">338</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma</a><div class="gs_gray">RJ Gilbertson, RH Perry, PJ Kelly, ADJ Pearson, J Lunec</div><div class="gs_gray">Cancer research 57 (15), 3272-3280<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13052050699066060013" class="gsc_a_ac gs_ibl">333</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Clinical and molecular stratification of disease risk in medulloblastoma</a><div class="gs_gray">R Gilbertson, C Wickramasinghe, R Hernan, V Balaji, D Hunt, ...</div><div class="gs_gray">British journal of cancer 85 (5), 705-712<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3601097073983431193" class="gsc_a_ac gs_ibl">196</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line</a><div class="gs_gray">DA Tweddle, AJ Malcolm, N Bown, ADJ Pearson, J Lunec</div><div class="gs_gray">Cancer research 61 (1), 8-13<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6953768097018548344" class="gsc_a_ac gs_ibl">195</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay</a><div class="gs_gray">K De Preter, F Speleman, V Combaret, J Lunec, G Laureys, BHJ Eussen, ...</div><div class="gs_gray">Modern Pathology 15 (2), 159-166<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=352278585845027551" class="gsc_a_ac gs_ibl">190</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value</a><div class="gs_gray">JK Mellon, J Lunec, C Wright, CHW Horne, P Kelly, DE Neal</div><div class="gs_gray">The Journal of urology 155 (1), 321-326<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1720846824810424900" class="gsc_a_ac gs_ibl">184</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer</a><div class="gs_gray">NC Levitt, FALM Eskens, KJ O’Byrne, DJ Propper, LJ Denis, SJ Owen, ...</div><div class="gs_gray">Clinical Cancer Research 7 (7), 1912-1922<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14767928811274662693" class="gsc_a_ac gs_ibl">177</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">The p53 pathway and its inactivation in neuroblastoma</a><div class="gs_gray">DA Tweddle, ADJ Pearson, M Haber, MD Norris, C Xue, C Flemming, ...</div><div class="gs_gray">Cancer letters 197 (1-2), 93-98<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1013807364923453807" class="gsc_a_ac gs_ibl">176</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Small-molecule inhibitors of the MDM2-p53 protein− protein interaction based on an isoindolinone scaffold</a><div class="gs_gray">IR Hardcastle, SU Ahmed, H Atkins, G Farnie, BT Golding, RJ Griffin, ...</div><div class="gs_gray">Journal of medicinal chemistry 49 (21), 6209-6221<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1749858041128062690" class="gsc_a_ac gs_ibl">156</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">High frequency of p53/MDM2/p14ARF pathway abnormalities in relapsed neuroblastoma</a><div class="gs_gray">J Carr-Wilkinson, K O'Toole, KM Wood, CC Challen, AG Baker, JR Board, ...</div><div class="gs_gray">Clinical cancer research 16 (4), 1108-1118<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9599082562431902040" class="gsc_a_ac gs_ibl">154</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67</a><div class="gs_gray">VM Tut, KL Braithwaite, B Angus, DE Neal, J Lunec, JK Mellon</div><div class="gs_gray">British Journal of cancer 84 (2), 270-275<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10800555736975439818" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">p53 is a direct transcriptional target of MYCN in neuroblastoma</a><div class="gs_gray">L Chen, N Iraci, S Gherardi, LD Gamble, KM Wood, G Perini, J Lunec, ...</div><div class="gs_gray">Cancer research 70 (4), 1377-1388<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16969223991421336336" class="gsc_a_ac gs_ibl">138</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Quality assessment of genetic markers used for therapy stratification</a><div class="gs_gray">IM Ambros, J Benard, M Boavida, N Bown, H Caron, V Combaret, ...</div><div class="gs_gray">Journal of clinical oncology 21 (11), 2077-2084<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5630204928953291451" class="gsc_a_ac gs_ibl">137</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Increased frequency of aberrations in the p53/MDM2/p14ARF pathway in neuroblastoma cell lines established at relapse</a><div class="gs_gray">J Carr, E Bell, ADJ Pearson, UR Kees, H Beris, J Lunec, DA Tweddle</div><div class="gs_gray">Cancer research 66 (4), 2138-2145<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2434892438030613203" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein− protein interaction: structure− activity studies leading to improved potency</a><div class="gs_gray">IR Hardcastle, J Liu, E Valeur, A Watson, SU Ahmed, TJ Blackburn, ...</div><div class="gs_gray">Journal of medicinal chemistry 54 (5), 1233-1243<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14757159341586462066" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Analysis of the p53 tumor‐suppressor gene in hepatocellular carcinomas from Britain</a><div class="gs_gray">C Challen, J Lunec, W Warren, J Collier, MF Bassendine</div><div class="gs_gray">Hepatology 16 (6), 1362-1366<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=686677531155239789" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma</a><div class="gs_gray">RJ Gilbertson, SC Clifford, W MacMeekin, C Wright, RH Perry, P Kelly, ...</div><div class="gs_gray">Cancer research 58 (17), 3932-3941<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10849339706838863737" class="gsc_a_ac gs_ibl">121</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:WF5omc3nYNoC" class="gsc_a_at">p53 cellular localization and function in neuroblastoma: evidence for defective G1 arrest despite WAF1 induction in MYCN-amplified cells</a><div class="gs_gray">DA Tweddle, AJ Malcolm, M Cole, ADJ Pearson, J Lunec</div><div class="gs_gray">The American journal of pathology 158 (6), 2067-2077<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16610961844178794073" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;citation_for_view=u3-iWPQAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Cultured human melanocytes respond to MSH peptides and ACTH</a><div class="gs_gray">G HUNT, PD DONATIEN, J LUNEC, C TODD, S KYNE, AJ THODY</div><div class="gs_gray">Pigment cell research 7 (4), 217-221<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5576936282244451240" class="gsc_a_ac gs_ibl">115</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:0EnyYjriUFMC" class="gsc_a_at">MYCN oncoprotein targets and their therapeutic potential</a><div class="gs_gray">E Bell, L Chen, T Liu, GM Marshall, J Lunec, DA Tweddle</div><div class="gs_gray">Cancer letters 293 (2), 144-157<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2090056364393516341" class="gsc_a_ac gs_ibl">113</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Isoindolinone-based inhibitors of the MDM2–p53 protein–protein interaction</a><div class="gs_gray">IR Hardcastle, SU Ahmed, H Atkins, AH Calvert, NJ Curtin, G Farnie, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 15 (5), 1515-1520<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5569678660606134620" class="gsc_a_ac gs_ibl">111</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:ufrVoPGSRksC" class="gsc_a_at">The expression of functional MSH receptors on cultured human melanocytes</a><div class="gs_gray">PD Donatien, G Hunt, C Pieron, J Lunec, A Taieb, AJ Thody</div><div class="gs_gray">Archives of dermatological research 284 (7), 424-426<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13016596883431623254" class="gsc_a_ac gs_ibl">110</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine</a><div class="gs_gray">JE Nutt, GC Durkan, JK Mellon, J Lunec</div><div class="gs_gray">BJU international 91 (1), 99-104<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9605136693890875855" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">The impact of p53 status on cellular sensitivity to antifolate drugs</a><div class="gs_gray">X Lu, J Errington, NJ Curtin, J Lunec, DR Newell</div><div class="gs_gray">Clinical Cancer Research 7 (7), 2114-2123<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18054534916882658896" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:Se3iqnhoufwC" class="gsc_a_at">c-erbB-2-amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder</a><div class="gs_gray">J Lunec, C Challen, C Wright, K Mellon, DE Neal</div><div class="gs_gray">Lancet (British edition) 339 (8790), 439-440<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=761421810232910855" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast</a><div class="gs_gray">GS Nouman, JJ Anderson, S Crosier, J Shrimankar, J Lunec, B Angus</div><div class="gs_gray">Journal of clinical pathology 56 (7), 507-511<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3086861262956710613" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma&nbsp;…</a><div class="gs_gray">RE George, RM Kenyon, AG McGuckin, AJ Malcolm, AD Pearson, ...</div><div class="gs_gray">Oncogene 12 (7), 1583-1587<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4806724228464502800" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63</a><div class="gs_gray">LD Gamble, UR Kees, DA Tweddle, J Lunec</div><div class="gs_gray">Oncogene 31 (6), 752-763<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6493042738452592147" class="gsc_a_ac gs_ibl">76</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">The role of the tumour suppressor p33ING1b in human neoplasia</a><div class="gs_gray">GS Nouman, JJ Anderson, J Lunec, B Angus</div><div class="gs_gray">Journal of clinical pathology 56 (7), 491-496<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9989510979152822416" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:hMod-77fHWUC" class="gsc_a_at">Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma</a><div class="gs_gray">KS Rankin, M Starkey, J Lunec, CH Gerrand, S Murphy, S Biswas</div><div class="gs_gray">Pediatric blood &amp; cancer 58 (3), 327-333<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12165374126060351773" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:5nxA0vEk-isC" class="gsc_a_at">The MYCN oncoprotein as a drug development target</a><div class="gs_gray">X Lu, A Pearson, J Lunec</div><div class="gs_gray">Cancer letters 197 (1-2), 125-130<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12957721151556723958" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">P53 overexpression in head and neck carcinoma and radiotherapy results</a><div class="gs_gray">S Awwad, E Jaros, J Somes, J Lunec</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 34 (2), 323-332<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8606115302043290050" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is&nbsp;…</a><div class="gs_gray">R Abdel-Fattah, C Challen, TRL Griffiths, MC Robinson, DE Neal, J Lunec</div><div class="gs_gray">British journal of cancer 77 (12), 2230-2238<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=944616475821955292" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Frequency of H‐<i>ras</i> mutations in human bladder cancer detected by direct sequencing</a><div class="gs_gray">SA Burchill, DE Neal, J Lunec</div><div class="gs_gray">British journal of urology 73 (5), 516-521<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12967063542536344236" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer</a><div class="gs_gray">GC Durkan, JE Nutt, C Marsh, PH Rajjayabun, MC Robinson, DE Neal, ...</div><div class="gs_gray">Clinical cancer research 9 (7), 2576-2582<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4471475725057437008" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Novel <i>ERBB4</i> juxtamembrane splice variants are frequently expressed in childhood medulloblastoma</a><div class="gs_gray">R Gilbertson, R Hernan, T Pietsch, L Pinto, P Scotting, R Allibone, ...</div><div class="gs_gray">Genes, Chromosomes and Cancer 31 (3), 288-294<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1247020120271067129" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Cell cycle regulation targets of MYCN identified by gene expression microarrays</a><div class="gs_gray">E Bell, J Lunec, D Tweddle</div><div class="gs_gray">Cell cycle 6 (10), 1249-1256<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2086952997740229135" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Non-glucose metabolism in cancer cells—is it all in the fat?</a><div class="gs_gray">S Biswas, J Lunec, K Bartlett</div><div class="gs_gray">Cancer and Metastasis Reviews 31 (3), 689-698<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2960294159888063332" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Loss of nuclear expression of the p33ING1b inhibitor of growth protein in childhood acute lymphoblastic leukaemia</a><div class="gs_gray">GS Nouman, JJ Anderson, KM Wood, J Lunec, AG Hall, MM Reid, ...</div><div class="gs_gray">Journal of clinical pathology 55 (8), 596-601<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1165924411481462445" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[131I] iodobenzylguanidine by neuroblastoma tumors</a><div class="gs_gray">S Carlin, RJ Mairs, AG McCluskey, DA Tweddle, A Sprigg, C Estlin, ...</div><div class="gs_gray">Clinical cancer research 9 (9), 3338-3344<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7186188991699660258" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors</a><div class="gs_gray">M Łastowska, S Cotterill, N Bown, C Cullinane, S Variend, J Lunec, ...</div><div class="gs_gray">Genes, Chromosomes and Cancer 34 (4), 428-436<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7520042962097351956" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:qUcmZB5y_30C" class="gsc_a_at">Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the&nbsp;…</a><div class="gs_gray">GC Durkan, JE Nutt, PH Rajjayabun, DE Neal, J Lunec, JK Mellon</div><div class="gs_gray">Clinical cancer research 7 (11), 3450-3456<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14658564785344868110" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:dhFuZR0502QC" class="gsc_a_at">Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells</a><div class="gs_gray">J Lunec, C Pieron, GV Sherbet, AJ Thody</div><div class="gs_gray">Pathobiology 58 (4), 193-197<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16595445054476041524" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours</a><div class="gs_gray">JE Nutt, JK Mellon, K Qureshi, J Lunec</div><div class="gs_gray">British Journal of Cancer 78 (2), 215-220<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4172943730760783057" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Heat-induced thermotolerance expressed in the energy metabolism of mammalian cells</a><div class="gs_gray">J Lunec, SR Cresswell</div><div class="gs_gray">Radiation research 93 (3), 588-597<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8672172053631645642" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues</a><div class="gs_gray">GS Nouman, B Angus, J Lunec, S Crosier, A Lodge, JJ Anderson</div><div class="gs_gray">Hybridoma and Hybridomics 21 (1), 1-10<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6480335721661720466" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:hC7cP41nSMkC" class="gsc_a_at">The role of MYCN in the failure of MYCN amplified neuroblastoma cell lines to G1 arrest after DNA damage</a><div class="gs_gray">E Bell, R Premkumar, J Carr, X Lu, PE Lovat, UR Kees, J Lunec, ...</div><div class="gs_gray">Cell Cycle 5 (22), 2639-2647<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7531924417202155818" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Gefitinib (‘Iressa’, ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2</a><div class="gs_gray">JE Nutt, HP Lazarowicz, JK Mellon, J Lunec</div><div class="gs_gray">British journal of cancer 90 (8), 1679-1685<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8164797542948388054" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">p53 and p53-regulated genes in bladder cancer.</a><div class="gs_gray">PE Keegan, J Lunec, DE Neal</div><div class="gs_gray">British journal of urology 82 (5), 710-720<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2205551547461584104" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Nuclear to cytoplasmic compartment shift of the p33<sup><i>ING1b</i></sup> tumour suppressor protein is associated with malignancy in melanocytic lesions</a><div class="gs_gray">GS Nouman, JJ Anderson, ME Mathers, N Leonard, S Crosier, J Lunec, ...</div><div class="gs_gray">Histopathology 40 (4), 360-366<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4069053610852581430" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:maZDTaKrznsC" class="gsc_a_at">A multilocus technique for risk evaluation of patients with neuroblastoma</a><div class="gs_gray">IM Ambros, B Brunner, G Aigner, C Bedwell, K Beiske, J Bénard, N Bown, ...</div><div class="gs_gray">Clinical Cancer Research 17 (4), 792-804<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12924575541767838129" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:IWHjjKOFINEC" class="gsc_a_at">Increased mdr 1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay</a><div class="gs_gray">SC Clifford, DJ Thomas, DE Neal, J Lunec</div><div class="gs_gray">British journal of cancer 69 (4), 680-686<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11712029790302542353" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis</a><div class="gs_gray">E Jaros, J Lunec, RH Perry, PJ Kelly, ADJ Pearson</div><div class="gs_gray">British journal of cancer 68 (4), 801-807<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2365361708527579337" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:4DMP91E08xMC" class="gsc_a_at">Hyperthermic enhancement of radiation cell killing in HeLa S3 cells and its effect on the production and repair of DNA strand breaks</a><div class="gs_gray">J Lunec, IP Hesslewood, R Parker, S Leaper</div><div class="gs_gray">Radiation research 85 (1), 116-125<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7428110207528723627" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">The role of folate receptor alpha (FR α) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy</a><div class="gs_gray">JE Nutt, ARA Razak, K O'toole, F Black, AE Quinn, AH Calvert, ...</div><div class="gs_gray">British journal of cancer 102 (3), 553-560<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3110640258570577569" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:8xutWZnSdmoC" class="gsc_a_at">A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage</a><div class="gs_gray">MJGW Ladds, IMM Van Leeuwen, CJ Drummond, S Chu, AR Healy, ...</div><div class="gs_gray">Nature communications 9 (1), 1-14<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9766035524508814562" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Heat shock factor-1 modulates p53 activity in the transcriptional response to DNA damage</a><div class="gs_gray">IR Logan, HV McNeill, S Cook, X Lu, DW Meek, FV Fuller-Pace, J Lunec, ...</div><div class="gs_gray">Nucleic acids research 37 (9), 2962-2973<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9181776259846614871" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:mB3voiENLucC" class="gsc_a_at">Relationship between histopathological features, <i>MYCN</i> amplification, and prognosis: A UKCCSG study</a><div class="gs_gray">RE George, S Variend, C Cullinane, SJ Cotterill, AG McGuckin, ...</div><div class="gs_gray">Medical and Pediatric Oncology: The Official Journal of SIOP—International&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3245929932842220384" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma</a><div class="gs_gray">L Chen, RF Rousseau, SA Middleton, GL Nichols, DR Newell, J Lunec, ...</div><div class="gs_gray">Oncotarget 6 (12), 10207<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2248805360169818717" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">MDM2-p53 protein–protein interaction inhibitors: A-ring substituted isoindolinones</a><div class="gs_gray">AF Watson, J Liu, K Bennaceur, CJ Drummond, JA Endicott, BT Golding, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 21 (19), 5916-5919<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9190233387665857988" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Analysis of the MDM2 antagonist nutlin‐3 in human prostate cancer cells</a><div class="gs_gray">IR Logan, HV McNeill, S Cook, X Lu, J Lunec, CN Robson</div><div class="gs_gray">The Prostate 67 (8), 900-906<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5174306980526374646" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma.</a><div class="gs_gray">J Lunec, C Pieron, AJ Thody</div><div class="gs_gray">Melanoma research 2 (1), 5-12<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=997350877033744240" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer</a><div class="gs_gray">M Zanjirband, RJ Edmondson, J Lunec</div><div class="gs_gray">Oncotarget 7 (26), 40115<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4027739821635936486" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:TFP_iSt0sucC" class="gsc_a_at">High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays</a><div class="gs_gray">J Carr, NP Bown, MC Case, AG Hall, J Lunec, DA Tweddle</div><div class="gs_gray">Cancer genetics and cytogenetics 172 (2), 127-138<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4173409964101601449" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">p53 is nuclear and functional in both undifferentiated and differentiated neuroblastoma</a><div class="gs_gray">L Chen, AJ Malcolm, KM Wood, M Cole, S Variend, C Cullinane, ...</div><div class="gs_gray">Cell cycle 6 (21), 2685-2696<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12087998011026188367" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:blknAaTinKkC" class="gsc_a_at">TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy formuscle-invasive bladder cancer</a><div class="gs_gray">KN Qureshi, TRL Griffiths, MC Robinson, C Marsh, JT Roberts, RR Hall, ...</div><div class="gs_gray">Clinical cancer research 5 (11), 3500-3507<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10581566372062297714" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:-f6ydRqryjwC" class="gsc_a_at">Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694</a><div class="gs_gray">SJ Freemantle, AL Jackman, LR Kelland, AH Calvert, J Lunec</div><div class="gs_gray">British journal of cancer 71 (5), 925-930<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6508171595029895650" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Accumulation of wild‐type p53 in meningiomas</a><div class="gs_gray">DW Ellison, J Lunec, PJ Gallagher, PV Steart, E Jaros, KC Gatter</div><div class="gs_gray">Neuropathology and applied neurobiology 21 (2), 136-142<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6940945843101210597" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Chemical inhibition of wild-type p53-induced phosphatase 1 (WIP1/PPM1D) by GSK2830371 potentiates the sensitivity to MDM2 inhibitors in a p53-dependent manner</a><div class="gs_gray">A Esfandiari, TA Hawthorne, S Nakjang, J Lunec</div><div class="gs_gray">Molecular cancer therapeutics 15 (3), 379-391<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14712388541342543447" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:TQgYirikUcIC" class="gsc_a_at">Mitotic percentage index: a new prognostic factor for childhood medulloblastoma</a><div class="gs_gray">RJ Gilbertson, E Jaros, RH Perry, PJ Kelly, J Lunec, ADJ Pearson</div><div class="gs_gray">European Journal of Cancer 33 (4), 609-615<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9501811758078910018" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?</a><div class="gs_gray">D Scott, J Elsden, A Pearson, J Lunec</div><div class="gs_gray">Cancer letters 197 (1-2), 81-86<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9105653358518913774" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Combined p21WAF1/CIP1 and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapy</a><div class="gs_gray">KN Qureshi, TRL Griffiths, MC Robinson, C Marsh, JT Roberts, J Lunec, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 51 (5), 1234-1240<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7957394861224368293" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Expression of cyclin‐dependent kinase inhibitor p21<sup>(WAF1)</sup> and p53 tumour suppressor gene in laryngeal cancer</a><div class="gs_gray">JP Jeannon, J Soames, J Lunec, S Awwad, V Ashton, JA Wilson</div><div class="gs_gray">Clinical Otolaryngology &amp; Allied Sciences 25 (1), 23-27<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=974843148169875345" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines</a><div class="gs_gray">M | fLastowska, N Van Roy, N Bown, F Speleman, J Lunec, T Strachan, ...</div><div class="gs_gray">Genes, Chromosomes and Cancer 23 (2), 116-122<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12343722538852215356" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Analysis of candidate gene co-amplification with MYCN in neuroblastoma</a><div class="gs_gray">RE George, R Kenyon, AG McGuckin, N Kohl, P Kogner, H Christiansen, ...</div><div class="gs_gray">European Journal of Cancer 33 (12), 2037-2042<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7507592665535796282" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:70eg2SAEIzsC" class="gsc_a_at">A novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissues</a><div class="gs_gray">AE Smith, M Pinkney, NH Piggott, H Calvert, ID Milton, J Lunec</div><div class="gs_gray">Hybridoma 26 (5), 281-288<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10813385874430756617" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:GnPB-g6toBAC" class="gsc_a_at">Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell&nbsp;…</a><div class="gs_gray">MJ Barnes, EJ Estlin, GA Taylor, GW Aherne, A Hardcastle, JJ McGuire, ...</div><div class="gs_gray">Clinical cancer research 5 (9), 2548-2558<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18177454859191883922" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:35N4QoGY0k4C" class="gsc_a_at">Histological profile of tumours from MYCN transgenic mice</a><div class="gs_gray">HC Moore, KM Wood, MS Jackson, MA Lastowska, D Hall, H Imrie, ...</div><div class="gs_gray">Journal of clinical pathology 61 (10), 1098-1103<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4061385037889333707" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Post-irradiation sensitization with the ADP-ribosyltransferase inhibitor 3-acetamidobenzamide.</a><div class="gs_gray">J Lunec, AM George, M Hedges, WA Cramp, WJ Whish, B Hunt</div><div class="gs_gray">The British journal of cancer. Supplement 6, 19<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13625836924964269121" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma</a><div class="gs_gray">CE Wu, A Esfandiari, YH Ho, N Wang, AK Mahdi, E Aptullahoglu, P Lovat, ...</div><div class="gs_gray">British journal of cancer 118 (4), 495-508<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7988186526646649271" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN&nbsp;…</a><div class="gs_gray">R Defferrari, K Mazzocco, IM Ambros, PF Ambros, C Bedwell, K Beiske, ...</div><div class="gs_gray">British journal of cancer 112 (2), 290-295<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13474288769082481343" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:RGFaLdJalmkC" class="gsc_a_at">erbB receptor expression patterns in human bladder cancer</a><div class="gs_gray">PH Rajjayabun, PE Keegan, J Lunec, JK Mellon</div><div class="gs_gray">Urology 66 (1), 196-200<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18130110813541766996" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">The neuroblastoma amplified gene, <i>NAG</i>: genomic structure and characterisation of the 7.3 kb transcript predominantly expressed in neuroblastoma</a><div class="gs_gray">DK Scott, JR Board, X Lu, ADJ Pearson, RM Kenyon, J Lunec</div><div class="gs_gray">Gene 307, 1-11<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7135203876017934953" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:BqipwSGYUEgC" class="gsc_a_at">High level expression of the multidrug resistance (MDRI) gene in the normal bladder urothelium: a potential involvement in protection against carcinogens?</a><div class="gs_gray">SC Clifford, DE Neal, J Lunec</div><div class="gs_gray">Carcinogenesis 17 (3), 601-604<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2317956083252166844,12417818738803792969" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder</a><div class="gs_gray">SC Clifford, DE Neal, J Lunec</div><div class="gs_gray">British journal of cancer 73 (5), 659-666<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2524754071922663665" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Effect of membrane fatty acid changes on the radiation sensitivity of human lymphoid cells</a><div class="gs_gray">AM George, J Lunec, WA Cramp</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=660384963267717186" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:k_IJM867U9cC" class="gsc_a_at">Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs</a><div class="gs_gray">H Liang, H Atkins, R Abdel-Fattah, SN Jones, J Lunec</div><div class="gs_gray">Gene 338 (2), 217-223<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4989873667385081189" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells</a><div class="gs_gray">JE Nutt, J Lunec</div><div class="gs_gray">European Journal of Cancer 32 (12), 2127-2135<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1721009454726158930" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-β1 genes in breast tumour cells</a><div class="gs_gray">JE Nutt, AL Harris, J Lunec</div><div class="gs_gray">British journal of cancer 64 (4), 671-676<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17923129888097605971" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Disruption of the MYC transcriptional function by a small-molecule antagonist of MYC/MAX dimerization</a><div class="gs_gray">X Lu, PK Vogt, DL Boger, J Lunec</div><div class="gs_gray">Oncology reports 19 (3), 825-830<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12293206600895980285" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma</a><div class="gs_gray">L Chen, Y Zhao, GC Halliday, P Berry, RF Rousseau, SA Middleton, ...</div><div class="gs_gray">British journal of cancer 111 (4), 716-725<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11725602125821050839" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl-N10-propargyl-5, 8-dideazafolic acid: a novel folate-based thymidylate synthase inhibitor</a><div class="gs_gray">BM O'Connor, AL Jackman, PH Crossley, SE Freemantle, J Lunec, ...</div><div class="gs_gray">Cancer research 52 (5), 1137-1143<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3575214010175070636" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase</a><div class="gs_gray">BG Sánchez, A Bort, PA Mateos-Gómez, N Rodríguez-Henche, ...</div><div class="gs_gray">Cancer cell international 19 (1), 1-14<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11122406189402646097,15371122163307730531" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia</a><div class="gs_gray">A Herriott, SJ Tudhope, G Junge, N Rodrigues, MJ Patterson, ...</div><div class="gs_gray">Oncotarget 6 (41), 43978<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8420148022159099415" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">The effects of benzamide ADP-ribosyl transferase inhibitors on cell survival and DNA strand-break repair in irradiated mammalian cells</a><div class="gs_gray">AM George, J Lunec, WA Cramp, S Brennan, PD Lewis, WJD Whish</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4736803702202704683" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">The predictive value of p53 and p33<sup><i>ING1b</i></sup> in patients with Dukes'C colorectal cancer</a><div class="gs_gray">IAM Ahmed, SB Kelly, JJ Anderson, B Angus, C Challen, J Lunec</div><div class="gs_gray">Colorectal Disease 10 (4), 344-351<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11237768172841761196" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma</a><div class="gs_gray">CPF Taylor, NP Bown, AG McGuckin, J Lunec, AJ Malcolm, ADJ Pearson, ...</div><div class="gs_gray">British journal of cancer 83 (1), 40-49<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9432279282557778553" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Carboplatin and paclitaxel, alone and in combination: dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene.</a><div class="gs_gray">AH Calvert, S Ghokul, A Al-Azraqi, J Wright, M Lind, N Bailey, M Highley, ...</div><div class="gs_gray">Seminars in oncology 26 (1 Suppl 2), 90-94<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16725115013269327688" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=u3-iWPQAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Isoindolin-1-one derivatives</a><div class="gs_gray">HMG Willems, P Kallblad, IR Hardcastle, RJ Griffin, BT Golding, J Lunec, ...</div><div class="gs_gray">US Patent 8,258,175<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5230451177233737962" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas</a><div class="gs_gray">K De Preter, F Speleman, V Combaret, J Lunec, J Board, A Pearson, ...</div><div class="gs_gray">Journal of clinical oncology 23 (13), 3167-3168<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7779421351444563457" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Diaryl-and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions</a><div class="gs_gray">TJ Blackburn, S Ahmed, CR Coxon, J Liu, X Lu, BT Golding, RJ Griffin, ...</div><div class="gs_gray">MedChemComm 4 (9), 1297-1304<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=682454979866293571" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene</a><div class="gs_gray">H Liang, J Lunec</div><div class="gs_gray">Gene 361, 112-118<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=753741059524540072" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Statistical problems with'optimal'thresholds in studies of new prognostic factors in urology</a><div class="gs_gray">PE Keegan, JNS MATTHEWS, J Lunec, DE Neal</div><div class="gs_gray">BJU international (Papier) 85 (4), 392-397<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6952896611348274816" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">The influence of pH on the enhancement of radiation damage by hyperthermia</a><div class="gs_gray">J Lunec, R Parker</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1980</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15023399336070331357" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1980</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines</a><div class="gs_gray">JE Nutt, K O’Toole, D Gonzalez, J Lunec</div><div class="gs_gray">European journal of cancer 45 (9), 1684-1691<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5896010306172375097" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Molecular biological changes in bladder cancer.</a><div class="gs_gray">KN Qureshi, J Lunec, DE Neal</div><div class="gs_gray">Cancer surveys 31, 77-97<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4916180010925900790" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer</a><div class="gs_gray">M Zanjirband, N Curtin, RJ Edmondson, J Lunec</div><div class="gs_gray">Oncotarget 8 (41), 69779<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11835274867685995791" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">A novel family of cathepsin L-like (CTSLL) sequences on human chromosome 10q and related transcripts</a><div class="gs_gray">SD Bryce, S Lindsay, AJ Gladstone, K Braithwaite, C Chapman, NK Spurr, ...</div><div class="gs_gray">Genomics 24 (3), 568-576<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14737815198421425100" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Introductory review: involvement of ADP-ribosylation in cellular recovery from some forms of DNA damage.</a><div class="gs_gray">J Lunec</div><div class="gs_gray">The British journal of cancer. Supplement 6, 13<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=899424322929492040" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:u_35RYKgDlwC" class="gsc_a_at">The Effect of Ultrasound at 1· 5 MHz on Escherichia Coli</a><div class="gs_gray">M Hedges, M Lewis, J Lunec, WA Cramp</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1980</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7753856635091011235" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1980</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Searching for Dual Inhibitors of the MDM 2‐p53 and MDMX‐p53 Protein–Protein Interaction by a Scaffold‐Hopping Approach</a><div class="gs_gray">A Zaytsev, B Dodd, M Magnani, C Ghiron, BT Golding, RJ Griffin, J Liu, ...</div><div class="gs_gray">Chemical biology &amp; drug design 86 (2), 180-189<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11885818945900665815" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:NhqRSupF_l8C" class="gsc_a_at">Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression</a><div class="gs_gray">J Carr-Wilkinson, R Griffiths, R Elston, LD Gamble, B Goranov, ...</div><div class="gs_gray">Cell Cycle 10 (21), 3778-3787<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11352643240209139083" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system</a><div class="gs_gray">A Burns, E Jaros, M Cole, R Perry, AJ Pearson, J Lunec</div><div class="gs_gray">British journal of cancer 86 (7), 1117-1123<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3685575398352304082" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:f2IySw72cVMC" class="gsc_a_at">Murine melanoma cell differentiation and melanogenesis induced by poly (ADP-ribose) polymerase inhibitors</a><div class="gs_gray">BW Durkacz, J Lunec, H Grindley, S Griffin, O Horner, A Simm</div><div class="gs_gray">Experimental cell research 202 (2), 287-291<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1818496542349154563" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:rO6llkc54NcC" class="gsc_a_at">A cautionary note on the use of thiol compounds to protect normal tissues in radiotherapy</a><div class="gs_gray">J Lunec, B Cullen, H Walker, S Hornsey</div><div class="gs_gray">The British journal of radiology 54 (641), 428-429<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18290222603047712438" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">A comparison of the effect of metal-bleomycin complexes on the DNA damage and survival of cultured mammalian cells</a><div class="gs_gray">AD Nunn, J Lunec</div><div class="gs_gray">European Journal of Cancer (1965) 14 (8), 857-863<span class="gs_oph">, 1978</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11050169123119454253" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1978</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma</a><div class="gs_gray">M Łastowska, N Van Roy, N Bown, F Speleman, P Roberts, J Lunec, ...</div><div class="gs_gray">Medical and Pediatric Oncology: The Official Journal of SIOP—International&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12975649725264477754" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:_axFR9aDTf0C" class="gsc_a_at">TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation</a><div class="gs_gray">CJ Drummond, A Esfandiari, J Liu, X Lu, C Hutton, J Jackson, ...</div><div class="gs_gray">Oncotarget 7 (29), 46203<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6035182717505568092" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation</a><div class="gs_gray">PJ Sung, N Boulos, MJ Tilby, WD Andrews, RF Newbold, DA Tweddle, ...</div><div class="gs_gray">Cancer letters 328 (1), 168-175<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14111690314505953141" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non–Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate&nbsp;…</a><div class="gs_gray">R Ramlau, M Thomas, S Novello, R Plummer, M Reck, T Kaneko, MR Lau, ...</div><div class="gs_gray">Clinical lung cancer 16 (5), 348-357<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9025691879302863381" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Membrane fluidity and the radiosensitivity of E. coli K1060</a><div class="gs_gray">T Alper, WA Cramp, A George, J Lunec, MB Yatvin</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18307898015481437868" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">ATM dependent DUSP6 modulation of p53 involved in synergistic targeting of MAPK and p53 pathways with trametinib and MDM2 inhibitors in cutaneous melanoma</a><div class="gs_gray">CE Wu, TS Koay, A Esfandiari, YH Ho, P Lovat, J Lunec</div><div class="gs_gray">Cancers 11 (1), 3<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18258821041374093234" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:08ZZubdj9fEC" class="gsc_a_at">The clinical development of p53-reactivating drugs in sarcomas–charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins</a><div class="gs_gray">S Biswas, E Killick, AG Jochemsen, J Lunec</div><div class="gs_gray">Expert opinion on investigational drugs 23 (5), 629-645<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6293246889983076423" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Molecular pathology and potential therapeutic targets in soft-tissue sarcoma</a><div class="gs_gray">R Todd, J Lunec</div><div class="gs_gray">Expert review of anticancer therapy 8 (6), 939-948<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16441272191596651068" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Cholesterol content and heat sensitivity of nine mammalian cell lines</a><div class="gs_gray">RL Anderson, J Lunec, SR Cresswell</div><div class="gs_gray">International journal of hyperthermia 1 (4), 337-347<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18371242732559210191" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma</a><div class="gs_gray">L Chen, F Pastorino, P Berry, J Bonner, C Kirk, KM Wood, HD Thomas, ...</div><div class="gs_gray">International journal of cancer 144 (12), 3146-3159<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8766744654015415796" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:u9iWguZQMMsC" class="gsc_a_at">Recombinant human MDM2 oncoprotein shows sequence composition selectivity for binding to both RNA and DNA</a><div class="gs_gray">C Challen, JJ Anderson, Z Chrzanowska‑Lightowlers, RN Lightowlers, ...</div><div class="gs_gray">International journal of oncology 40 (3), 851-859<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12991975184146673265" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQ TM in human leukaemia and colorectal carcinoma cell lines</a><div class="gs_gray">EJ Estlin, K Balmanno, AH Calvert, AG Hall, J Lunec, DR Newell, ...</div><div class="gs_gray">British journal of cancer 76 (12), 1579-1585<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3131586216824888124" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:a0OBvERweLwC" class="gsc_a_at">Post-irradiation inhibition of scheduled DNA synthesis and stimulation of ADP-ribosylation in sensitive and resistant L5178Y murine lymphoma cells</a><div class="gs_gray">J Lunec, S Guo Qi, AM George, WJD Whish, WA Cramp</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13717088634347839273" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:0N-VGjzr574C" class="gsc_a_at">Surgical outcome and patterns of recurrence for retroperitoneal sarcoma at a single centre</a><div class="gs_gray">HDJ Hogg, DM Manas, D Lee, P Dildey, J Scott, J Lunec, JJ French</div><div class="gs_gray">The Annals of The Royal College of Surgeons of England 98 (03), 192-197<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13578568697011409379" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours</a><div class="gs_gray">JE Nutt, PA Foster, JK Mellon, J Lunec</div><div class="gs_gray">British journal of cancer 96 (5), 762-768<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13587513482243932213" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">The extent of bonding of newly synthesized DNA to parent template in unirradiated cells as a prediction of radiation sensitivity</a><div class="gs_gray">WA Cramp, J Lunec, A George, S Cresswell, PD Lewis, S Chamberlain, ...</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2610404817036276241" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:_xSYboBqXhAC" class="gsc_a_at">A transient post-irradiation defect in newly synthesised DNA</a><div class="gs_gray">WA Cramp, AM George, J Lunec, G Harris, I Olsen, PD Lewis, ...</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5528487110937879444" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:0CzhzZyukY4C" class="gsc_a_at">Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells</a><div class="gs_gray">C Ciardullo, E Aptullahoglu, L Woodhouse, WY Lin, JP Wallis, H Marr, ...</div><div class="gs_gray">haematologica 104 (12), 2429<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10282321079495033694" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Poly (ADP-Ribose) polymerase in cervical cancer pathogenesis: Mechanism and potential role for PARP inhibitors</a><div class="gs_gray">IC Kotsopoulos, A Kucukmetin, A Mukhopadhyay, J Lunec, NJ Curtin</div><div class="gs_gray">International Journal of Gynecologic Cancer 26 (4)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5880419043790962377" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">MDM2 RNA binding is blocked by novel monoclonal antibody h-MDM2-F4-14</a><div class="gs_gray">JJ Anderson, C Challen, H Atkins, R Suaeyun, S Crosier, J Lunec</div><div class="gs_gray">International journal of oncology 31 (3), 545-555<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11116770404301521230" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:SP6oXDckpogC" class="gsc_a_at">MSH receptors and function in amelanotic B16 melanoma cells.</a><div class="gs_gray">J Lunec, C Pieron, W Bal, S MacNeil, AJ Thody</div><div class="gs_gray">Melanoma research 3 (2), 99-106<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12041959452790610730" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">DNA repair and repair fidelity in metastatic variants of the B16 murine melanoma</a><div class="gs_gray">BA Usmani, J Lunec, GV Sherbet</div><div class="gs_gray">Journal of cellular biochemistry 51 (3), 336-344<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2976991898219910606" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:abG-DnoFyZgC" class="gsc_a_at">The Response of E. Coli Bs− 1 to Tritium-β Particles under Aerated and Anoxic Conditions</a><div class="gs_gray">J Lunec, WA Cramp</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1978</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5283573640214275933" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1978</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:PELIpwtuRlgC" class="gsc_a_at">COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib</a><div class="gs_gray">E Bell, F Ponthan, C Whitworth, DA Tweddle, J Lunec, CPF Redfern</div><div class="gs_gray">Clinical &amp; experimental metastasis 31 (6), 651-659<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4356444921151682389" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">The ErbB2 receptor represents a potential target for novel therapies in childhood medulloblastoma.</a><div class="gs_gray">RJ Gilbertson, R Hernan, ADJ Pearson, J Lunec</div><div class="gs_gray">CLINICAL CANCER RESEARCH 5, 3737S-3737S<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1488972940420952016" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response</a><div class="gs_gray">CE Wu, TS Koay, YH Ho, P Lovat, J Lunec</div><div class="gs_gray">Cancer cell international 19 (1), 1-15<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2562057966698465715" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:dshw04ExmUIC" class="gsc_a_at">Pigment cells are able to synthesize MSH pepties (abstr)</a><div class="gs_gray">J LUNECC</div><div class="gs_gray">J Invest dermatol 91, 407<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5930019825819126708" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein–Protein Interaction</a><div class="gs_gray">G Chessari, IR Hardcastle, JS Ahn, B Anil, E Anscombe, RH Bawn, ...</div><div class="gs_gray">Journal of Medicinal Chemistry 64 (7), 4071-4088<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9805164656750716577" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Expression of p33/ING1 gene products in colorectal cancer and its correlation with survival</a><div class="gs_gray">IAM Ahmed, GS Nouman, J Lunec, SB Kelly, JJ Anderson, B Angus</div><div class="gs_gray">Gastroenterology 5 (120), A300<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=604198662353534680" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Monoclonal antibodies raised to products of the ING1 tumour suppressor gene locus.</a><div class="gs_gray">GS Nouman, B Angus, J Lunec, JJ Anderson</div><div class="gs_gray">JOURNAL OF PATHOLOGY 192, 26A-26A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12900996028679715747" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">A frequent target for genetic abnormalities in human hepatocellular carcinoma in Britain</a><div class="gs_gray">C Challen</div><div class="gs_gray">He patology 14, 94A<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2773400845905534879" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Differences in repair in heterogeneous cell populations in vivo and in vitro following high LET irradiation (neutrons).</a><div class="gs_gray">S Hornsey, J Lunec, C Griffin</div><div class="gs_gray">The British journal of cancer. Supplement 6, 145<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10315765964954462975" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:BzfGm06jWhQC" class="gsc_a_at">Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers</a><div class="gs_gray">CE Wu, YR Pan, CN Yeh, J Lunec</div><div class="gs_gray">Biomolecules 10 (11), 1474<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7478736825016918852" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable <i>MYCN</i>-Nonamplified Neuroblastomas. Report From the SIOPEN Biology&nbsp;…</a><div class="gs_gray">IM Ambros, GP Tonini, U Potschger, N Gross, V Mosseri, K Beiske, ...</div><div class="gs_gray">Journal of Clinical Oncology<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18098408935425276276" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours</a><div class="gs_gray">L Chen, A Esfandiari, W Reaves, A Vu, MD Hogarty, J Lunec, DA Tweddle</div><div class="gs_gray">International journal of oncology 52 (3), 967-977<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5470108884394798245" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells</a><div class="gs_gray">IR Logan, UL McClurg, DL Jones, DJ O'Neill, FS Shaheen, J Lunec, ...</div><div class="gs_gray">Oncotarget 7 (46), 74724<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11828542564959698072" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:UxriW0iASnsC" class="gsc_a_at">Sequencing of ING1 tumour suppressor gene cDNAs generated from mRNA recovered from normal and neoplastic cell lines.</a><div class="gs_gray">GS Nouman, JJ Anderson, B Angus, J Lunec</div><div class="gs_gray">JOURNAL OF PATHOLOGY 192, 26A-26A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9760077852435564206" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Molecular biology and bladder cancer</a><div class="gs_gray">J Lunec, JK Mellon</div><div class="gs_gray">Tumours in Urology, 19-45<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10477963730534860285" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:738O_yMBCRsC" class="gsc_a_at">The response of murine lymphoma cells—L5178Y S &amp; R—to heat at 44° C</a><div class="gs_gray">S Cresswell, J Lunec, J Ledda, WA Cramp</div><div class="gs_gray">Cell biology international reports 4 (12), 1065-1073<span class="gs_oph">, 1980</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10607711398054478751" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1980</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Cytotoxicity of various bleomycins to cultured mammalian cells</a><div class="gs_gray">AD Nunn, J Lunec</div><div class="gs_gray">Bleomycin: Chemical, Biochemical, and Biological Aspects, 287-296<span class="gs_oph">, 1979</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17470727249055926918" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1979</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor</a><div class="gs_gray">M Franklin, L Gentles, E Matheson, N Bown, P Cross, A Ralte, ...</div><div class="gs_gray">Cancer medicine 7 (9), 4744-4754<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8785608108575919528" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">Functional characterisation of a novel ovarian cancer cell line, NUOC-1</a><div class="gs_gray">A McCormick, E Earp, K Elliot, G Cuthbert, R O'Donnell, BT Wilson, ...</div><div class="gs_gray">Oncotarget 8 (16), 26832<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5537084595439974753" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:W5xh706n7nkC" class="gsc_a_at">p53 and p53-regulated genes in bladder cancer.</a><div class="gs_gray">JP Crew, A Jones</div><div class="gs_gray">BJU international 83 (4), 529-530<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18130395583151771299" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with WAF1, p53 and Ki67</a><div class="gs_gray">V TUT, K BRAITHWAITE, B Angus, D NEAL, J Lunec, J MELLON</div><div class="gs_gray">British Journal of Urology 82 (1)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15292448818692936415" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Monoclonality of multiple bladder cancers</a><div class="gs_gray">RTD Oliver, DN Feldman, D Sidransky, B Vogelstein, P Frost, ...</div><div class="gs_gray">New England Journal of Medicine 327 (6), 433-435<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7305170015258058263" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients</a><div class="gs_gray">V Manoharan, EH Karunanayake, KH Tennekoon, S De Silva, ...</div><div class="gs_gray">BMC cancer 20 (1), 1-15<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3444750954490478903" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:43bX7VzcjpAC" class="gsc_a_at">55P Evaluation of MDM2-p53 antagonists, nutlin-3 and RG7388, combined with the PARPi rucaparib in primary cultures of ovarian cancer</a><div class="gs_gray">M Zanjirband, L Gentles, NJ Curtin, RL O'Donnell, J Lunec</div><div class="gs_gray">Annals of Oncology 31, S1234<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12669174689254313369" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Nucleotide variants and protein expression of TP53 in a Sri Lankan cohort of patients with head and neck cancer</a><div class="gs_gray">V Manoharan, EH Karunanayake, KH Tennekoon, S De Silva, K De Silva, ...</div><div class="gs_gray">Molecular medicine reports 19 (4), 2781-2791<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9544971318235491584" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Highly potent clickable probe for cellular imaging of MDM2 and assessing dynamic responses to MDM2-p53 inhibition</a><div class="gs_gray">H Lebraud, RA Noble, N Phillips, K Heam, J Castro, Y Zhao, DR Newell, ...</div><div class="gs_gray">Bioconjugate chemistry 29 (6), 2100-2106<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17465687702133618083" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ODE9OILHJdcC" class="gsc_a_at">Abstract P3-07-21: Cytotoxic potential of the RG7388 MDM2-p53 binding antagonist and the GSK2830371 WIP1 inhibitor on MX-1 and MCF-7 human breast cancer cells</a><div class="gs_gray">V Manoharan, J Lunec, A Esfandiari, A Mahdi, CE Wu, M Zanjirband, ...</div><div class="gs_gray">Cancer Research 77 (4 Supplement), P3-07-21-P3-07-21<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=319053584523905185" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">IN VITRO SINGLE AGENT RUCAPARIB CYTOTOXICITY AND CISPLATIN CHEMO-POTENTIATION IN CERVICAL CANCER CELL LINES</a><div class="gs_gray">IC Kotsopoulos, JA Begbie, A Mukhopadhyay, J Lunec, NJ Curtin, ...</div><div class="gs_gray">16th Biennial Meeting of the International Gynecologic Cancer Society<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10649082103963746962" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP): A predictive biomarker of chemotherapy response in osteosarcoma</a><div class="gs_gray">S Biswas, K Rankin, A Long, S Nisar, C Gerrand, P Dildey, J Lunec</div><div class="gs_gray">Cancer Research 72 (8 Supplement), 5580-5580<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2135843462609276197" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Evaluation of p53 mutation as a predictive biomarker for outcome to chemotherapy in ovarian cancer.</a><div class="gs_gray">AH Calvert, JC Jackson, C Hutton, AM Swart, W Qian, C Kwakye, ...</div><div class="gs_gray">Journal of Clinical Oncology 29 (15_suppl), 10522-10522<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5424042812013942280" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Cellular pharmacokinetic and activity studies with the MDM2-p53 inhibitor Nutlin-3</a><div class="gs_gray">Y Zhao, H Thomas, J Lunec, DR Newell</div><div class="gs_gray">Cancer Research 70 (8 Supplement), 4529-4529<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1601234956526338025" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">A monoclonal antibody for detection of folylpolyglutamate synthetase in paraffin embedded tissues</a><div class="gs_gray">AE Quinn, M Pinkney, NH Piggott, H Calvert, ID Milton, J Lunec</div><div class="gs_gray">Hybridoma 28 (6), 415-421<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1767785086055843018" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:D_sINldO8mEC" class="gsc_a_at">Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis</a><div class="gs_gray">ARA Razak, JE Nutt, K O'Toole, F Black, ER Plummer, AH Calvert, ...</div><div class="gs_gray">Lung Cancer: 7th Annual BTOG Meeting<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15163343046198539728" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">437 POSTER MDM2 and MDMX status as a determinant of in vitro cellular sensitivity to MDM2 antagonists in human tumour cell lines</a><div class="gs_gray">X Lu, J Liu, A Watson, IR Hardcastle, RJ Griffin, BT Golding, DR Newell, ...</div><div class="gs_gray">Ejc Supplements 12 (6), 137<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10326469494167923163" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Isoindolinone based inhibitors of the MDM2-p53 protein-protein interaction</a><div class="gs_gray">SJ Kemp, IR Hardcastle, SU Ahmed, NA Atatreh, P Barrett, JA Endicott, ...</div><div class="gs_gray">ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 230, U2735-U2736<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17537670768024392966" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Increased susceptibility of MDM2 amplified cell lines to MDM2-p53 inhibitors is associated with a high turnover of MDM2 and p53</a><div class="gs_gray">SU Ahmed, C Hutton, J Lunec</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 695-695<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12420033563796176040" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:8AbLer7MMksC" class="gsc_a_at">The molecular biology of bladder cancer</a><div class="gs_gray">PE Keegan, DE Neal, J Lunec</div><div class="gs_gray">Treatment Options in Urological Cancer, 59-83<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11635672830102704042" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">p33 (ING1b) tumour suppresser protein expression in thyroid lesions determined by immunohistochemistry</a><div class="gs_gray">GS Nouman, JJ Anderson, S Crosier, S Johnson, J Lunec, B Angus</div><div class="gs_gray">Journal of Pathology 195, 37A-37A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11701039719973822711" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:DUooU5lO8OsC" class="gsc_a_at">Radical radiotherapy and muscle-invasive bladder cancer: combined WAF1 and TP53 over-expression predict improved survival</a><div class="gs_gray">K QURESHI, TRL GRIFFITHS, M ROBINSON, C MARSH, J ROBERTS, ...</div><div class="gs_gray">Bju International 84 (1)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16936566733357090685" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Expression and characterisation of novel ErbB-4 alternative spliced variants by childhood</a><div class="gs_gray">RJ Gilbertson, R Hernan, P Scotting, D Walker, ADJ Pearson, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 80, 86-86<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17624082795128724122" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Muscle-invasive bladder cancer treated by radical radiotherapy: combined WAF1 and TP53 overexpression predict improved survival</a><div class="gs_gray">K Qureshi, TRL Griffiths, M Robinson, C Marsh, J Roberts, D Neal, ...</div><div class="gs_gray">Bju International-Supplement 83<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10292629843882112911" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">Urinary Matrix Metalloproteinase-1 (MMP-1) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in Bladder Cancer: a decreased MMP-1 TIMP-1 Ratio is Associated with Muscle Invasion</a><div class="gs_gray">GC Durkan, JE Nutt, DE Neal, J Lunec, JK Mellon</div><div class="gs_gray">The Journal of Urology 161 (4S)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12445324740009474589" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Chemotherapy and muscle-invasive bladder cancer: TP53 and MDM2 immuno-reactivity (IR) as predictors of response</a><div class="gs_gray">KN Qureshi, TRL Griffiths, MC Robinson, C Marsh, RR Hall, J Lunec, ...</div><div class="gs_gray">The Journal of Urology 161 (4S)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4593106980452795031" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">MDM2 and p53 immunoreactivity; independent predictors of stage progression in pT1 bladder cancer (TCC)</a><div class="gs_gray">PE Keegan</div><div class="gs_gray">Br J Urol 81 (4), 14<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4642041499688383145" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:geHnlv5EZngC" class="gsc_a_at">P53, C-ERB-2 AND EGFR IN BLADDER-CANCER</a><div class="gs_gray">K Mellon, C Wright, J Lunec, AL HARRIS, DP LANE, CHW HORNE, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 63 (5), 834-834<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11024637499154664745" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">The effect of the inhibition of poly (ADP-ribose) polymerase on radiation sensitivity</a><div class="gs_gray">AM George, J Lunec, M Hedges, GQ SUN, SA Sabovljev, WA Cramp, ...</div><div class="gs_gray">International Journal of Radiation Biology 44 (1), 107-108<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14285850828108136283" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">POST-IRRADIATION SENSITIZATION IN MOUSE AND HUMAN-CELLS BY AN INHIBITOR OF ADP-RIBOSYLTRANSFERASE</a><div class="gs_gray">J Lunec, A GEORGE, WJD Whish, M Hedges, WA Cramp</div><div class="gs_gray">British Journal of Radiology 56 (669), 693-694<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13421743825453358691" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Post-irradiation defects in newly synthesized DNA: neutrons and electrons compared and the effect of misonidazole</a><div class="gs_gray">GQ Sun, AM George, J Lunec, S Cresswell, WA Cramp</div><div class="gs_gray">International Journal of Radiation Biology and Related Studies in Physics&nbsp;…<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12620249099486250377" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:sSrBHYA8nusC" class="gsc_a_at">The influence of hyperthermia on the repair of radiation induced DNA strand breaks and cell killing in HeLa S3 cells</a><div class="gs_gray">IP Hesslewood, J Lunec, R Parker, S Leaper</div><div class="gs_gray">Radiation biology and chemistry<span class="gs_oph">, 1979</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6833285158385730187" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1979</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Co‑localisation of intra‑nuclear membrane type‑1 matrix metalloproteinase and hypoxia inducible factor‑2α in osteosarcoma and prostate carcinoma cells</a><div class="gs_gray">CD Chan, EJ Haagensen, HA Tensaout, KJ Rennie, Z Gamie, J Barry, ...</div><div class="gs_gray">Oncology Letters 21 (2), 1-1<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Preclinical Investigation of the p53-MDM2 Antagonist Idasanutlin (RG7388) Demonstrates Significant Activity in High Risk Adult Acute Lymphoblastic Leukemia</a><div class="gs_gray">HL Bell, M Singh, HJ Blair, FW van Delft, AV Moorman, J Lunec, J Irving</div><div class="gs_gray">Blood 136, 38<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia</a><div class="gs_gray">EW Law, L McKenzie, H Blair, D Bulmer, D Pal, K Szoltysek, J Lunec, ...</div><div class="gs_gray">Klinische Pädiatrie 232 (03)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:zCSUwVk65WsC" class="gsc_a_at">Targeting the MDM2-p53 interaction: evaluation of a novel, potent MDM2-p53 antagonist in patient-derived CLL cells</a><div class="gs_gray">E Willmore, E Aptullahoglu, Y Zhao, S Kyle, H Thomas, M Ahn, L Fazal, ...</div><div class="gs_gray">LEUKEMIA &amp; LYMPHOMA 61, 81-81<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:jgBuDB5drN8C" class="gsc_a_at">The spliceosome inhibitor E7107 induces a dose-dependent cytotoxicity in CLL cells and produces aberrantly spliced transcripts and protein products of p53 pathway genes</a><div class="gs_gray">E Aptullahoglu, J Wallis, H Marr, S Marshall, E Willmore, J Lunec</div><div class="gs_gray">LEUKEMIA &amp; LYMPHOMA 61, 266-267<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Hepatitis C virus infection, endogenous retrotransposons activation and cancer risk</a><div class="gs_gray">R Shukla, HL Reeves, S McPherson, M McCain, P Sudhindar, Y Bury, ...</div><div class="gs_gray">Journal of Hepatology<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:lvd772isFD0C" class="gsc_a_at">The anti-proliferative and pro-apoptotic effect of MDM2-p53 antagonists evaluated in human tumor cells lines and chronic lymphocytic leukemia patient samples</a><div class="gs_gray">E Willmore, Y Zhao, C Ciardullo, L Woodhouse, HD Thomas, M Ahn, ...</div><div class="gs_gray">Cancer Research 78 (13 Supplement), 1870-1870<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:5MTHONV0fEkC" class="gsc_a_at">PO-445 E7107 treatment results in aberrantly spliced transcripts and protein products of P53 pathway genes</a><div class="gs_gray">E Aptullahoglu, JP Wallis, H Marr, S Marshall, E Willmore, J Lunec</div><div class="gs_gray">ESMO Open 3, A197<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">PO-450 MEK inhibition synergizes with MDM2 inhibitors through DUSP6 suppression</a><div class="gs_gray">CE Wu, TS Koay, A Esfandiari, YH Ho, P Lovat, J Lunec</div><div class="gs_gray">ESMO Open 3, A198<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ALROH1vI_8AC" class="gsc_a_at">Investigating novel drug combinations against patient-derived xenografts of acute lymphoblastic leukaemia</a><div class="gs_gray">E Law, L McKenzie, K Szoltysek, J Lunec, J Irving, J Vormoor, ...</div><div class="gs_gray">Klinische Pädiatrie 230 (03), 16<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:GFxP56DSvIMC" class="gsc_a_at">What drives development of HCC in non-cirrhotic NAFLD?</a><div class="gs_gray">A Mahdi, M Zaki, J Lunec, Q Anstee, D Tiniakos, R Shukla, F Oakley, ...</div><div class="gs_gray">Journal of Hepatology 68, S49<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:nZcligLrVowC" class="gsc_a_at">Activation of p53 by the MDM2 antagonist RG7388 in CLL cells: analyses of ex vivo signaling, cell death and gene signature</a><div class="gs_gray">E Willmore, C Ciardullo, E Aptullahoglu, L Woodhouse, J Wallis, J Lunec, ...</div><div class="gs_gray">LEUKEMIA &amp; LYMPHOMA 58, 187-188<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Lipogranulomas, neutrophils and the progression of NAFLD to NASH and HCC</a><div class="gs_gray">JC Mauricio, AK Mahdi, J Lunec, G Patman, A Whitehead, D Tiniakos, ...</div><div class="gs_gray">HEPATOLOGY 66, 987A-988A<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:HeT0ZceujKMC" class="gsc_a_at">MDM2 inhibition for non-genotoxic activation of TP53-a novel strategy for the treatment of hepatocellular carcinoma (HCC)</a><div class="gs_gray">AK Mahdi, HD Thomas, S Wedge, R Shukla, H Reeves, J Lunec</div><div class="gs_gray">HEPATOLOGY 66, 369A-369A<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:fFSKOagxvKUC" class="gsc_a_at">Abstract LB-300: In vivo evaluation of the intravenous MDM2-p53 antagonist RO6839921 alone and in combination with temozolomide in <i>TP53</i> wild-type orthotopic&nbsp;…</a><div class="gs_gray">L Chen, F Pastorino, P Berry, J Bonner, K Wood, G Veal, M Ponzoni, ...</div><div class="gs_gray">Cancer Research 77 (13 Supplement), LB-300-LB-300<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:3htObqc8RwsC" class="gsc_a_at">Inhibition of WIP1/PPM1D phosphatase by GSK2830371 potentiates the growth inhibitory and cytotoxic activity of MDM2 antagonists (nutlin-3, RG7388 and HDM201) in cutaneous&nbsp;…</a><div class="gs_gray">CE Wu, A Esfandiari, YH Ho, C Shepherd, AK Mahdi, E Aptullahoglu, ...</div><div class="gs_gray">Cancer Research 77 (13 Supplement), 2151-2151<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Cytotoxic potential of the RG7388 MDM2-p53 binding antagonist and the GSK2830371 WIP1 inhibitor on MX-1 and MCF-7 human breast cancer cells</a><div class="gs_gray">V Manoharan, J Lunec, A Esfandiari, A Mahdi, CE Wu, M Zanjirband, ...</div><div class="gs_gray">CANCER RESEARCH 77<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:gVv57TyPmFsC" class="gsc_a_at">In vivo evaluation of the intravenous MDM2-p53 antagonist RO6839921 alone and in combination with temozolomide in <i>TP53</i> wild-type orthotopic models of&nbsp;…</a><div class="gs_gray">L Chen, F Pastorino, P Berry, J Bonner, K Wood, G Veal, M Ponzoni, ...</div><div class="gs_gray">AACR Annual Meeting 2017<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Transcriptomic consequences of MDMX (MDM4) oncoprotein expression knockdown in MDMX-amplified breast cancer cells</a><div class="gs_gray">Y Ho, C Hutton, H Newell, J Lunec</div><div class="gs_gray">Cancer Research 76 (14 Supplement), 3701-3701<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:GtLg2Ama23sC" class="gsc_a_at">The p53-MDM2 Antagonist RG7388 Activates p53 and Induces a Predominantly Pro-Apoptotic Gene Expression Signature in Chronic Lymphocytic Leukemia</a><div class="gs_gray">C Ciardullo, L Woodhouse, E Aptullahoglu, JP Wallis, HJ Marr, ...</div><div class="gs_gray">Blood 128 (22), 893<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:YohjEiUPhakC" class="gsc_a_at">MDM2 antagonists− a therapeutic approach for patients with hepatocellular carcinoma?</a><div class="gs_gray">A Mahdi, J Lunec, H Reeves</div><div class="gs_gray">European Journal of Cancer 1 (61), S44<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Non-genotoxic activation of p53 by nutlin-3 does not activate DUSP6 in melanoma cells</a><div class="gs_gray">CE Wu, YH Ho, A Esfandiari, P Lovat, J Lunec</div><div class="gs_gray">Pigment Cell &amp; Melanoma Research 28 (6)<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:Aul-kAQHnToC" class="gsc_a_at">Design and synthesis of dual inhibitors of the MDM2-p53 and MDMX-p53 protein-protein interactions</a><div class="gs_gray">S Adhikari, C Cano, B Golding, I Hardcastle, S Harnor, C Jennings, ...</div><div class="gs_gray">ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Chemical inhibition or transient knockdown of wild-type p53 induced phosphatase 1 (WIP1/PPM1D) potentiates the response to MDM2 inhibitors in a p53-dependent manner</a><div class="gs_gray">A Esfandiari, NJ Curtin, J Lunec</div><div class="gs_gray">Cancer Research 75 (15 Supplement), 1785-1785<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:VLnqNzywnoUC" class="gsc_a_at">Assessment and targeting of the MDM2-p53 network in CLL</a><div class="gs_gray">L Woodhouse, C Crawford, S Marshall, N Bown, J Wallis, G Summerfield, ...</div><div class="gs_gray">Cancer Research 75 (15 Supplement), 5263-5263<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels</a><div class="gs_gray">S Tudhope, Y Zhao, A Wittner, E Wilmore, A Bertoli, S Adhikari, SJ Harnor, ...</div><div class="gs_gray">Cancer Research 74 (19 Supplement), 5451-5451<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Nutlin-3 is cytotoxic in TP53 WT liposarcoma and leiomyosarcoma in vitro and can act both synergistically and antagonistically with ionising radiation</a><div class="gs_gray">HDJ Hogg, JJ French, J Lunec</div><div class="gs_gray">Abstracts from the Society of Academic and Research Surgery (SARS) Annual&nbsp;…<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">276 An X-ray crystal structure-based understanding of the inhibition of the MDM2–p53 protein–protein interaction by isoindolinones</a><div class="gs_gray">B Anil, E Blackburn, T Blackburn, S Cully, J Liu, CJ Drummond, ...</div><div class="gs_gray">European Journal of Cancer, 91-92<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Validation studies with small-molecule modulators of the MDM2/MDMX-p53 binding interaction</a><div class="gs_gray">A Bertoli, S Adhikari, SJ Harnor, Y Zhao, J Lunec, SR Wedge, S Tudhope, ...</div><div class="gs_gray">247th ACS National Meeting and Exposition<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">The effect of hypoxia on temporal and spatial membrane type-1 matrix metalloproteinase (MT1-MMP) expression in osteosarcoma</a><div class="gs_gray">K Rankin, S Nisar, H Morfitt, S Biswas, J Lunec, M Birch, C Gerrand</div><div class="gs_gray">Orthopaedic Proceedings 95 (SUPP_1), 114-114<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Regiospecific synthesis of isoindolinones as MDM2 inhibitors</a><div class="gs_gray">SJ Cully, TJ Blackburn, C Cano, BT Golding, RJ Griffin, J Lunec, D Newell, ...</div><div class="gs_gray">245th ACS National Meeting and Exposition<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Cytotoxicity of Various Bleomycins</a><div class="gs_gray">AD NUNN, J LUNEC</div><div class="gs_gray">Bleomycin: Chemical, Biochemical, and Biological Aspects: Proceedings of a&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Design and preclinical pharmacological evaluation of a cleavable succinate ester solubilizing group for isoindolinone MDM2-p53 protein-protein interaction inhibitors</a><div class="gs_gray">Y Zhao, H Thomas, J Liu, TJ Blackburn, S Cully, AF Watson, IR Hardcastle, ...</div><div class="gs_gray">Cancer Research 72 (8 Supplement), 919-919<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">The prognostic role of MT1-MMP and HIF Isoforms in Human Osteosarcoma</a><div class="gs_gray">S Biswas, KS Rankin, A Long, J Jackson, R Howard, S Nisar, M Birch, ...</div><div class="gs_gray">American Association for Cancer Research (AACR)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">MDMX expression is linked with MYCN amplification or expression in neuroblastoma, and sensitizes cells to MDM2-p53 antagonists</a><div class="gs_gray">LD Gamble, DA Tweddle, J Lunec</div><div class="gs_gray">Cancer Research 71 (8 Supplement), 612-612<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:foquWX3nUaYC" class="gsc_a_at">Expression of methylthioadenosine phosphorylase (MTAP) in malignant pleural mesothelioma (MPM) and its implication for pemetrexed-based chemotherapy</a><div class="gs_gray">AA Razak, J Nutt, K O'Toole, F Black, M Cole, R Plummer, J Lunec, ...</div><div class="gs_gray">EJC Supplements: 22nd EORTC-NCI-AACR Symposium on Molecular Targets and&nbsp;…<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:gsN89kCJA0AC" class="gsc_a_at">442 Triarylpyrroles, dual inhibitors of the MDM2-p53 and MDMX-p53 protein–protein interactions</a><div class="gs_gray">T Blackburn, H Ahmed, CR Coxon, BT Golding, RJ Griffin, H Newell, J Liu, ...</div><div class="gs_gray">Ejc Supplements 7 (8), 139-140<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:EYYDruWGBe4C" class="gsc_a_at">available at www. sciencedirect. com</a><div class="gs_gray">S Aebi, D August, P Autier, A Banham, C Bennett, J Blazeby, F Bonnetain, ...</div><div class="gs_gray">European Journal of Cancer 46, 216<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Abstract A154: Mechanisms of cellular resistance to the growth inhibitory and cytotoxic effects of MDM2‐p53 binding antagonists</a><div class="gs_gray">J Liu, X Lu, C Drummond, C Hutton, J Jackson, K Bennaceur, D Newell, ...</div><div class="gs_gray">Molecular Cancer Therapeutics 8 (12 Supplement), A154-A154<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:5ugPr518TE4C" class="gsc_a_at">Abstract A140: Identification of substituted isoindolinones as potent inhibitors of the MDM2‐p53 protein‐protein interaction</a><div class="gs_gray">A Watson, J Liu, E Armstrong, T Blackburn, JA Endicott, BT Golding, ...</div><div class="gs_gray">Molecular Cancer Therapeutics 8 (12 Supplement), A140-A140<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Abstract# 4716: Characterisation of cell lines selected for resistance to MDM2-p53 binding antagonists</a><div class="gs_gray">J Liu, X Lu, I Hardcastle, D Newell, J Lunec</div><div class="gs_gray">Cancer Research 69 (9 Supplement), 4716-4716<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Abstract# 3447: Evidence that p53 is a direct transcriptional target of MYCN in neuroblastoma</a><div class="gs_gray">L Chen, N Iraci, G Perini, J Lunec, D Tweddle</div><div class="gs_gray">Cancer Research 69 (9 Supplement), 3447-3447<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Abstract# 3446: MYCN interaction with the p53/MDM2/p14ARF network in neuroblastoma and response to p53-MDM2 antagonists</a><div class="gs_gray">L Gamble, D Tweddle, J Lunec</div><div class="gs_gray">Cancer Research 69 (9 Supplement), 3446-3446<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">The wide variation in response of mesothelioma cell lines to pemetrexed and lack of relationship to presence of folate receptor alpha (Fra).</a><div class="gs_gray">JE Nutt, ARA Razak, J Lunec</div><div class="gs_gray">Lung Cancer, S26<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">MEDI 147-Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction</a><div class="gs_gray">AF Watson, BT Golding, RJ Griffin, C Hutton, J Liu, X Lu, J Lunec, ...</div><div class="gs_gray">ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 236<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:5icHVeHT4IsC" class="gsc_a_at">MEDI 147-Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction</a><div class="gs_gray">E Valeur, IR Hardcastle, BT Golding, C Hutton, RJ Griffin, J Lunec, ...</div><div class="gs_gray">Abstracts of Papers of the American Chemical Society: 236th National Meeting&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Identifying gene expression changes involved in the differentiation of neuroblastoma cells</a><div class="gs_gray">S Pei-Ju, N Boulos, D Tweddle, J Lunec</div><div class="gs_gray">Cancer Research 67 (9 Supplement), 1810-1810<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:hkOj_22Ku90C" class="gsc_a_at">Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on clinical outcome of patients with early breast cancer after adjuvant treatment&nbsp;…</a><div class="gs_gray">S Beare, A Boddy, J Nutt, K O'Toole, J Lunec</div><div class="gs_gray">Cancer Research 67 (9 Supplement), 747-747<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:5awf1xo2G04C" class="gsc_a_at">Cell cycle targets of MYCN identified by gene expression microarray</a><div class="gs_gray">E Bell, J Lunec, D Tweddle</div><div class="gs_gray">Cancer Research 67 (9 Supplement), 4446-4446<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">The development and evaluation of novel monoclonal antibodies to folate receptor alpha and folylpolyglutamate synthetase for use on paraffin embedded samples</a><div class="gs_gray">A Smith, M Pinkney, N Piggott, A Kucukmetin, R Edmondson, A Calvert, ...</div><div class="gs_gray">Cancer Research 67 (9 Supplement), LB-167-LB-167<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:EkHepimYqZsC" class="gsc_a_at">Inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.</a><div class="gs_gray">IR Hardcastle, SU Ahmed, PA Barrett, JA Endicott, BT Golding, RJ Griffin, ...</div><div class="gs_gray">CLINICAL CANCER RESEARCH 11 (24), 9053S-9054S<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Studies in NQO2 SNPs and NRH: CB1954 reductase activity in human bladder tumors</a><div class="gs_gray">D Jamieson, K Wilson, S Pridgeon, HY Leung, J Lunec, A Boddy</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 322-322<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Activation of the p53 pathway by small molecular weight inhibitors of the MDM2-p53 interaction</a><div class="gs_gray">SU Ahmed, H Atkins, J Endicott, G Farnie, BT Golding, RJ Griffin, J Gruber, ...</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 1450-1450<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Aberrations of the p53/p14ARF/MDM2 pathway in neuroblastoma cell lines derived from progressive and/or relapsed tumours</a><div class="gs_gray">J Carr, ADJ Pearson, UR Kees, J Lunec, DA Tweddle</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 687-688<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:z_wVstp3MssC" class="gsc_a_at">Comparison between MYCN status as a determinant of in vitro cellular chemosensitivity and clinical response to chemotherapy in human neuroblastoma</a><div class="gs_gray">X Lu, DA Tweddle, ADJ Pearson, J Lunec</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 691-691<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">Thymidylate synthase assessed in the primary tumour is not an accurate predictor of metastasis or survival in Dukes'c colorectal cancer</a><div class="gs_gray">IA Ahmed, B Angus, S Kelly, J Lunec</div><div class="gs_gray">GASTROENTEROLOGY 128 (4), A159-A159<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:uWiczbcajpAC" class="gsc_a_at">P53 AND MDM2 IN SOFT TISSUE SARCOMAS</a><div class="gs_gray">R Todd, C Challen, P Dildey, S Murray, C Gerrand, M Verrill, H Calvert, ...</div><div class="gs_gray">Orthopaedic Proceedings 87 (SUPP_I), 79-79<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Non-destructive in-vitro modelling of bladder cancer invasion–does multiphoton microscopy hold the key?</a><div class="gs_gray">H LAZAROWICZ, J NUTT, T BOOTH, A WHITAKER, J KELLY, J MELLON, ...</div><div class="gs_gray">Bju International 94 (7), 1161-1162<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:epqYDVWIO7EC" class="gsc_a_at">The effect of gefitinib (‘Iressa’, ZD1839) on bladder cancer cell growth and cell signalling in ras mutated and non-mutated bladder cancer cell lines</a><div class="gs_gray">HP Lazarowicz, JE Nutt, JK Mellon, J Lunec</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 1049-1050<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">Identification of MYCN transcriptional activity inhibitors yields compounds which preferentially inhibit the growth of neuroblastoma cells</a><div class="gs_gray">X Lu, DR Newell, ADJ Pearson, J Lunec</div><div class="gs_gray">Advanced Neuroblastoma Research<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:J-pR_7NvFogC" class="gsc_a_at">122 Identification of inhibitors of the MDM2-p53 interaction using a virtual screening approach with multiple binding modes</a><div class="gs_gray">IR Hardcastle, SU Ahmed, S Guyenne, C Hutton, P Kallblad, S Kemp, ...</div><div class="gs_gray">EJC Supplements 8 (2), 39-40<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">1p deleted neuroblastoma cells differentiate following chromosome 1 reintroduction</a><div class="gs_gray">N Boulos, RF Newbold, DA Trott, ADJ Pearson, MJ Tilby, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S18-S18<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:LhH-TYMQEocC" class="gsc_a_at">The effect of gefitinib (Iressa™, ZD1839) and trastuzumab (herceptin) on the human bladder cancer cell line 5637: P068</a><div class="gs_gray">P RAJJAYABUN, T BOOTH, J KELLY, J LUNEC, J MELLON</div><div class="gs_gray">Bju International-Supplement 91, 61-62<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Molecular Oncology, Markers, Clinical Correlates-Development of a Real-Time Polymerase Chain Reaction Assay for Prediction of the Uptake of Meta-(131I) iodobenzylguanidine by&nbsp;…</a><div class="gs_gray">S Carlin, RJ Mairs, AG McCluskey, DA Tweddle, A Sprigg, C Estlin, ...</div><div class="gs_gray">Clinical Cancer Research 9 (9), 3338-3344<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Molecular Oncology, Markers, Clinical Correlates-Alteration in Urinary Matrix Metalloproteinase-9 to Tissue Inhibitor of Metalloproteinase-1 Ratio Predicts Recurrence in&nbsp;…</a><div class="gs_gray">GC Durkan, JE Nutt, C Marsh, PH Rajjayabun, MC Robinson, DE Neal, ...</div><div class="gs_gray">Clinical Cancer Research 9 (7), 2576-2582<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:_B80troHkn4C" class="gsc_a_at">Inhibition of the MDM2-p53 interaction as a potential target in cancer therapy</a><div class="gs_gray">G Farnie, S Ahmed, J Lunec</div><div class="gs_gray">BJC: British Journal of Cancer 88, S34-S34<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Selection for p53 mutant cells by chemotherapy in high-risk neuroblastoma</a><div class="gs_gray">J Carr-Wilkinson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:MLfJN-KU85MC" class="gsc_a_at">TP53 and p33 (Ing1) are co-determinants of prognosis in colorectal cancer.</a><div class="gs_gray">I Ahmed, GS Nouman, SB Kelly, N Bailey, JJ Anderson, B Angus, J Lunec</div><div class="gs_gray">GASTROENTEROLOGY 122 (4), A124-A124<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Quantification of MYCN, DDX1, and NAG Gene Copy Number in Neuroblastoma Using a Real-Time Quantitative PCR Assay</a><div class="gs_gray">F Speleman, PSV Combaret, J Lunec, G Laureys, BHJ Eussen, ...</div><div class="gs_gray">Genetic study of high-stage neuroblastomas and normal neuroblastoma&nbsp;…<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:yFnVuubrUp4C" class="gsc_a_at">Irène van der Bracht, hoogleraar lichamelijke opvoeding, eerste vrouwelijke hoogleraar aan de RUG</a><div class="gs_gray">M Thiery</div><div class="gs_gray">Nationaal biografisch woordenboek 16 16, 168-172<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">p33<sup>ING1b</sup> tumour suppressor immunohistochemical expression in invasive breast carcinomas</a><div class="gs_gray">GS Nouman, JJ Anderson, S Crosier, J Shrimankar, J Lunec, B Angus</div><div class="gs_gray">184th Meeting of The Pathological Society of Great Britain and Ireland<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Functional complementation analysis of chromosome 1 in neuroblastoma</a><div class="gs_gray">N Boulos, RF Newbold, DA Trott, ADJ Pearson, MJ Tilby, J Lunec</div><div class="gs_gray">BJC: British Journal of Cancer 86, S91-S91<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">The Editors of the European Journal of Cancer would like to take this opportunity to express their gratitude to all of the individuals who acted as referees in the Year 2002&nbsp;…</a><div class="gs_gray">CJ Baines, J Going, P Peeters, AJM Balm, M Gore, GJ Peters, J Bernier, ...</div><div class="gs_gray">European Journal of Cancer 38, 2477<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:LI9QrySNdTsC" class="gsc_a_at">p33 (ING1b) tumour suppresser protein expression in melanocytic lesions, an immunohistochemical study of 67 cases</a><div class="gs_gray">GS Nouman, JJ Anderson, ME Mathers, N Leonard, S Crosier, J Lunec, ...</div><div class="gs_gray">JOURNAL OF PATHOLOGY 195, 12A-12A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">p33 (ING1b) tumour suppresser protein expression in childhood acute lymphoblastic leukaemia by immunohistochemistry</a><div class="gs_gray">GS Nouman, JJ Anderson, J Lunec, AG Hall, MM Reid, B Angus</div><div class="gs_gray">JOURNAL OF PATHOLOGY 195, 34A-34A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">ZD1839 ('Iressa') inhibits the growth response of bladder tumour cell lines to Epidermal Growth Factor and the induction of TIMP1</a><div class="gs_gray">JE Nutt, JK Mellon, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 85, 53-53<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ipzZ9siozwsC" class="gsc_a_at">The dependence of p63 induction and activity on poly (ADP-ribose) polymerase-1</a><div class="gs_gray">PA Jowsey, G Farnie, BW Durkacz, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 85, 80-80<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Identification of novel coding exons within the neuroblastoma amplified gene, NAG.</a><div class="gs_gray">DK Scott, ADJ Pearson, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 85, 78-78<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">p33/ING1 Nuclear Expression in Colorectal Cancer and its Correlation with Metastasis and Survival</a><div class="gs_gray">I Ahmed, G Nouman, S Kelly, J Lunec, J Anderson, B Angus</div><div class="gs_gray">Colorectal Disease 3<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Novel ErbB4 juxtamembrane splice variants and the truncated ErbB2 receptor isoform are frequently expressed in childhood medulloblastoma</a><div class="gs_gray">RJ Gilbertson, R Hernan, J Lewin, T Pietsch, L Pinto, P Scotting, ...</div><div class="gs_gray">Genes, Chromosomes &amp; Cancer<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:WZBGuue-350C" class="gsc_a_at">Regular Articles-Molecular Oncology, Markers, Clinical Correlates-Prognostic Significance of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 in Voided&nbsp;…</a><div class="gs_gray">GC Durkan, JE Nutt, PH Rajjayabun, DE Neal, J Lunec, JK Mellon</div><div class="gs_gray">Clinical Cancer Research 7 (11), 3450-3456<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:vbGhcppDl1QC" class="gsc_a_at">Inhibiting the MDM2-p53 interaction using low molecular weight compounds</a><div class="gs_gray">G Farnie, H Atkins, AH Calvert, NJ Curtin, BT Golding, RJ Griffin, ...</div><div class="gs_gray">BRIT J CANCER 85, 81-81<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Is DDX1 an oncogene? How does its pattern of expression relate to its amplification status?</a><div class="gs_gray">JL Elsden, RM Kenyon, RE George, R Godbout, ADJ Pearson, J Lunec</div><div class="gs_gray">British Cancer Research Meeting 2001<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:e_rmSamDkqQC" class="gsc_a_at">Expression of cyclin‐dependent kinase inhibitor p21<sup>(WAFI)</sup> and p53 tumour suppressor gene in laryngeal cancer</a><div class="gs_gray">JP Jeannon, J Soames, J Lunec, S Awwaad, V Ashton, JA Wilson</div><div class="gs_gray">Clinical Otolaryngology &amp; Allied Sciences 25 (5), 431-431<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Detection of amplified and transcribed sequences at the chromosome 12q13-15 locus in NGP neuroblastoma cells by Alu-PCR</a><div class="gs_gray">LIB Pinto, ADJ Pearson, R Perry, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 83, 36-36<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:WqliGbK-hY8C" class="gsc_a_at">CELLULAR AND MOLECULAR PATHOLOGY-Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma</a><div class="gs_gray">CPF Taylor, NP Bown, AG McGuckin, J Lunec, AJ Malcolm, ADJ Pearson, ...</div><div class="gs_gray">British Journal of Cancer 83 (1), 40-49<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">A decreased urinary matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 ratio is associated with muscle invasion in bladder cancer</a><div class="gs_gray">G DURKAN, J NUTT, D NEAL, J LUNEC, J MELLON</div><div class="gs_gray">Bju International 84 (1), 141-142<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:_5tno0g5mFcC" class="gsc_a_at">TP53 and MDM2 immunoreactivity as predictors of response in muscle-invasive bladder cancer treated by systemic chemotherapy</a><div class="gs_gray">K QURESHI, TRL GRIFFITHS, M ROBINSON, C MARSH, R HALL, ...</div><div class="gs_gray">Bju International 84 (1), 140-141<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">Matrix metalloproteinase-1 and epidermal growth factor receptor in bladder cancer: immunohistochemical expression and relationship to urinary matrix metalloproteinase-1&nbsp;…</a><div class="gs_gray">G DURKAN, J NUTTZ, C MARSH, M ROBINSON, D NEAL, J LUNEC, ...</div><div class="gs_gray">Bju International 84 (1)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Graft inhibitor LY309887 cytotoxicity correlates with ATP depletion but not with p53 status in human tumour cell lines</a><div class="gs_gray">X Lu, J Errington, J Lunec, VJ Chen, NJ Curtin, AV Boddy, DR Newell</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 80, 49-49<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Can the acidic domain of the MDM2 oncoprotein act as a transcriptional transactivation domain?</a><div class="gs_gray">CL Bladen, AD Sharrocks, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 80, 73-73<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Matrixmetalloproteinase stimulation in bladder tumour cell lines and elevated levels in the urine of bladder tumour patients.</a><div class="gs_gray">JE Nutt, G Durkan, K Mellon, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 80, 37-37<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Combined WAF1 and TP53 overexpression predict improved survival in muscle-invasive bladder cancer</a><div class="gs_gray">K Qureshi, T Griffiths, M Robinson, C Marsh, J Roberts, J Lunec, D Neal, ...</div><div class="gs_gray">The British Journal of Surgery 86<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">Urinary MMP-1 and TIMP-1 in bladder cancer: association with mechanisms of progression and epidermal growth factor receptor status</a><div class="gs_gray">G Durkan, J Nutt, C Marsch, M Robinson, D Neal, J Lunec, J Mellon</div><div class="gs_gray">The British Journal of Surgery 86, 1-2<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:OTTXONDVkokC" class="gsc_a_at">P27Kip1 in TCC of the bladder: expression is not related to clinical outcome, as in prostate cancer</a><div class="gs_gray">J Mellon, E Kemp, K Braithwaite, D Neal, J Anderson, K Wood, J Lunec</div><div class="gs_gray">Bju International-Supplement 83<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:umqufdRvDiIC" class="gsc_a_at">Immunohistochemical expression of matrix metalloproteinase-1 (MMP-1) and epidermal growth factor receptor (EGFR) in bladder cancer, and its relationship to urinary MMP-1&nbsp;…</a><div class="gs_gray">G Durkan, J Nutt, C Marsh, M Robinson, D Neal, J Lunec, J Mellon</div><div class="gs_gray">Bju International-Supplement 83<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:-FonjvnnhkoC" class="gsc_a_at">Statistical problems with'optimal'cut-points in studies of new prognostic factors in urology</a><div class="gs_gray">P Keegan, JNS Matthews, J Lunec, D Neal</div><div class="gs_gray">Bju International-Supplement 83<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:rmuvC79q63oC" class="gsc_a_at">Combined Waf1 and Tp53 Over-Expression Predict Improved Survival In Patients With Muscle-Invasive Bladder Cancer Treated By Radical Radiotherapy</a><div class="gs_gray">KN Qureshi, TRL Griffiths, MC Robinson, C Marsh, JT Roberts, DE Neal, ...</div><div class="gs_gray">The Journal of Urology 161 (4S)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">p53 and p53-regulated genes in bladder cancer-Reply</a><div class="gs_gray">PE Keegan, J Lunec, DE Neal</div><div class="gs_gray">BJU INTERNATIONAL 83 (4), 529-530<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:HIFyuExEbWQC" class="gsc_a_at">p53 and p53-regulated genes in bladder cancer</a><div class="gs_gray">PE Keegan, J Lunec, DE Neal</div><div class="gs_gray">Bju International 83 (4), 529-530<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Experimental Therapeutics, Preclinical Pharmacology-Impact of Polyglutamation on Sensitivity to Raltitrexed and Methotrexate in Relation to Drug-induced Inhibition of de Novo&nbsp;…</a><div class="gs_gray">MJ Barnes, EJ Estlin, GA Taylor, GW Aherne, A Hardcastle, JJ McGuire, ...</div><div class="gs_gray">Clinical Cancer Research 5 (9), 2548-2558<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Molecular Oncology, Markers, Clinical Correlates-TP53 Accumulation Predicts Improved Survival in Patients Resistant to Systemic Cisplatin-based Chemotherapy for Muscle-invasive&nbsp;…</a><div class="gs_gray">KN Qureshi, TRL Griffiths, MC Robinson, C Marsh, JT Roberts, RR Hall, ...</div><div class="gs_gray">Clinical Cancer Research 5 (11), 3500-3507<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Bcl-2 expression is a potential prognostic co-factor with P53-mutation status in epithelial ovarian carcinoma</a><div class="gs_gray">A Al-Azraqi, B Angus, S Gokul, D Sinha, AH Calvert, J Lunec</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Cyclin D1 expression in TCC of the bladder: correlation with WAF1, p53 and Ki67</a><div class="gs_gray">V Tut, K Braithwaite, B Angus, D Neal, J Lunec, J Mellon</div><div class="gs_gray">British Journal of Urology-Supplement 81<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Neuroblastoma cells provoke Schwann cell proliferation in vitro</a><div class="gs_gray">R George, S Variend, C Cullinane, S Cotterill, A McGuckin, C Ellershaw, ...</div><div class="gs_gray">8th Advances in Neuroblastoma Research Meeting<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:XoXfffV-tXoC" class="gsc_a_at">Chemotherapy and muscle-invasive bladder cancer: Assessment of p53 immuno-reactivity (IR) as a predictor of response</a><div class="gs_gray">KN Qureshi, TRL Griffiths, C Marsh, MC Robinson, RR Hall, J Lunec, ...</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">TP53 and related protein expression in primary and metastatic neuroblastoma</a><div class="gs_gray">DA Tweddle, AJ Malcolm, MM Reid, M Cole, J Lunec, ADJ Pearson</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Evaluation of the yeast functional (FASAY) assay for detecting p53 mutations in bladder cancers</a><div class="gs_gray">W Scaife, K Braithwaite, R Abdel-Fattah, DE Neal, J Lunec</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Does TP53 function in neuroblastoma?</a><div class="gs_gray">DA Tweddle, ADJ Pearson, AJ Malcolm, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 78, 28-28<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:p__nRnzSRKYC" class="gsc_a_at">Genomic mapping of the human MDM2 oncogene and the relationship between exon/intron boundaries and variant MDM2 transcripts</a><div class="gs_gray">H Liang, H Atkins, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 78, 64-64<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:vDijr-p_gm4C" class="gsc_a_at">A novel p53 binding sequence in intron 3 of the human MDM2 proto-oncogene: A putative additional p53-dependent promoter</a><div class="gs_gray">H Liang, J Lunec</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 78, 18-18<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Expression of cyclin dependent kinase inhibitors in laryngeal cancer</a><div class="gs_gray">JP Jeannon, JV Soames, J Lunec, JA Wilson, CG Kelly</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Does the acidic domain of the MDM2 oncoprotein have a transcriptional control function?</a><div class="gs_gray">C Bladen, J Lunec</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:SdhP9T11ey4C" class="gsc_a_at">Thymidylate synthase expression in nolatrexed and methotrexate-resistant human leukaemia cell lines</a><div class="gs_gray">EJ Estlin, AG Hall, J Lunec, DR Newell, ADJ Pearson, GA Taylor</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 78, 25-25<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Expression of p53, Waf-1, Bcl-2, and Bax in central primitive neuroectodermal tumours (cPNET)</a><div class="gs_gray">A Burns, E Jaros, ADJ Pearson, RH Perry, J Lunec</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:4vMrXwiscB8C" class="gsc_a_at">Peptide growth factors and erb B oncogenes in bladder cancer: The effect of EGFr status on clinical outcome</a><div class="gs_gray">D Neal, J Mellon, J Lunec, CH Horne</div><div class="gs_gray">The Australian &amp; New Zealand Journal of Surgery 66 (6), 378-379<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Analysis of the N-myc amplicon in neuroblastoma</a><div class="gs_gray">RM Kenyon, RE George, AG McGuckin, ADJ Pearson, J Lunec</div><div class="gs_gray">Clinical Oncology 3 (8), 202<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">DEMONSTRATION OF SPECIFIC MELANOCYTE STIMULATING HORMONE RECEPTORS ON HUMAN MELANOCYTES GROWN IN A SYSTEM FREE OF ARTIFICIAL MITOGENS</a><div class="gs_gray">PD DONATIEN, G HUNT, A TAIEB, J LUNEC, AJ THODY</div><div class="gs_gray">JOURNAL OF INVESTIGATIVE DERMATOLOGY 98 (4), 541-541<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:olpn-zPbct0C" class="gsc_a_at">Poly (ADP-ribose) polymerase inhibitors induce murine melanoma cell differentiation by a mechanism independent of alterations in cAMP levels and protein kinase A activity</a><div class="gs_gray">BW Durkacz, J Lunec, H Grindley, S Griffin, O Horne, A Simm</div><div class="gs_gray">ADP-Ribosylation Reactions, 191-194<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase Inhibitors</a><div class="gs_gray">J Lunec, W Warren, J Collier, M Bassendine</div><div class="gs_gray">Cancer Cells 3, 1<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:N5tVd3kTz84C" class="gsc_a_at">EFFECTS OF ESTRADIOL, TPA AND BRYOSTATIN ON GROWTH, THE TRANSCRIPTIONAL REGULATION OF ESTROGEN RESPONSIVE GENES AND THE EXPRESSION OF TGF-BETA IN HUMAN BREAST-TUMOR LINES</a><div class="gs_gray">J NUTT, AL HARRIS, J LUNEC</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 62 (3), 489-490<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ye4kPcJQO24C" class="gsc_a_at">Interactive effects of estradiol, TPA and bryostatin on growth and on the expression of estrogen responsive genes and TGF-β in human breast tumour lines</a><div class="gs_gray">J Nutt, AL Harris, J Lunec</div><div class="gs_gray">European Journal of Cancer and Clinical Oncology 26 (2), 179<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">DNA-REPAIR FIDELITY AND RECOMBINATION PROFICIENCY IN B-16 MELANOMA METASTATIC VARIANTS</a><div class="gs_gray">BA USMANI, GV SHERBET, J LUNEC</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 60 (3), 482-482<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:tYavs44e6CUC" class="gsc_a_at">Epidermal growth-factor receptor expression in primary breast-tumor tissue</a><div class="gs_gray">J Lunec, S Nicholson, J Fennelly, C Parker, GV Sherbet, AL Harris</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">The isolation of CDNA clones for cysteine proteases and measurement of the expression of corresponding genes in metastatic variants of B-16 melanoma</a><div class="gs_gray">J Lunec, C Parker, GV Sherbet</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Possible Autocrine Control of Growth and Progression of Melanonma by Alpha-MSH</a><div class="gs_gray">J Lunec, C Fisher, C Parker, GV Sherbet, AJ Thody</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:JQOojiI6XY0C" class="gsc_a_at">GENOMIC REARRANGEMENTS AND DIFFERENTIAL EXPRESSION IN RADIATION RESISTANT L5178Y MURINE LYMPHOMA-CELLS</a><div class="gs_gray">J LUNEC, DJ SHERRATT</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 56 (2), 220-220<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">The generation of metastatic mosaicism in B-16 murine melanoma</a><div class="gs_gray">GV Sherbet, MS Lakshmi, J Lunec, SS Bhattacharya, C Parker</div><div class="gs_gray">British Journal of Cancer<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:M7yex6snE4oC" class="gsc_a_at">RBE FOR STROMAL ENDOTHELIAL DAMAGE</a><div class="gs_gray">S HORNSEY, J LUNEC, R MYERS, A BEGG, N TERRY</div><div class="gs_gray">INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 46 (5), 646-646<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:URolC5Kub84C" class="gsc_a_at">MODIFICATION OF REPAIR OF LESIONS IN DNA-DISCUSSION</a><div class="gs_gray">J LUNEC, AM GEORGE, EA BLAKELY, JT LETT, WA CRAMP, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 49, 79-80<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">INFLUENCE OF RADIATION QUALITY ON REPAIR PROCESSES-DISCUSSION</a><div class="gs_gray">S HORNSEY, U BERTSCHE, J LUNEC, J KIEFER, D HARDER, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 49, 187-189<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">The effect of hyperthermia on hydrogen-transfer systems in mouse lymphoma cells</a><div class="gs_gray">GUOQUI SUN, J LUNEC, S CRESSWELL, W CRAMP</div><div class="gs_gray">Biochemical Society Transactions 10 (5), 366-367<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Investigations into subcellular mechanisms of thermotolerance: energy metabolism and heat-shock proteins</a><div class="gs_gray">J Lunec, R Anderson, SR Cresswell</div><div class="gs_gray">Strahlentherapie;(Germany, Federal Republic of) 158 (6)<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:KUbvn5osdkgC" class="gsc_a_at">The effect of hyperthermia on hydrogen-transfer systems in mouse lymphoma cells. Abstr.</a><div class="gs_gray">GQ Sun, J Lunec, S Cresswell, W Cramp</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:tzM49s52ZIMC" class="gsc_a_at">EXPRESSION OF HEAT-INDUCED THERMOTOLERANCE IN THE ENERGY-METABOLISM OF MURINE LYMPHOMA-CELLS</a><div class="gs_gray">J LUNEC, SR CRESSWELL</div><div class="gs_gray">BRITISH JOURNAL OF RADIOLOGY 55 (654), 470-470<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">A TECHNIQUE TO PREDICT AND FOLLOW THE BIOLOGICAL EFFECTS OF RADIATION AND HEAT</a><div class="gs_gray">WA CRAMP, J LUNEC, A GEORGE, S CRESSWELL, G HARRIS, ...</div><div class="gs_gray">BRITISH JOURNAL OF RADIOLOGY 54 (644), 709-710<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:NJ774b8OgUMC" class="gsc_a_at">ROLE OF LOW PH, LACTIC AND BETA-HYDROXYBUTYRIC ACIDS IN CELL KILLING BY HYPERTHERMIA</a><div class="gs_gray">J LUNEC, R PARKER, SR CRESSWELL</div><div class="gs_gray">BRITISH JOURNAL OF RADIOLOGY 54 (648), 1117-1117<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Neutron irradiation of bacteria in the presence and absence of secondary charged-particle equilibrium</a><div class="gs_gray">J Lunec, WA Cramp, S Hornsey</div><div class="gs_gray">Radiation research 83 (3), 607-620<span class="gs_oph">, 1980</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1980</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Are serum-copper levels important in bleomycin therapy?</a><div class="gs_gray">J Lunec, AD Nunn</div><div class="gs_gray">The Lancet 314 (8145), 739<span class="gs_oph">, 1979</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1979</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Drummond CJ, Esfandiari A, Liu J, Lu X, Hutton C, Jackson J, Bennaceur K, Xu Q, Makimanejavali AR, Bello FD, Piergentili A, Newell DR, Hardcastle IR</a><div class="gs_gray">RJ Griffin, J Lunec</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Zaytsev A, Dodd B, Magnani M, Ghiron C, Golding BT, Griffin RJ, Liu J, Lu X</a><div class="gs_gray">I Micco, DR Newell, A Padova, G Robertson, J Lunec, IR Hardcastle</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:otzGkya1bYkC" class="gsc_a_at">McCormick A, Earp E, Elliot K, Cuthbert G, O'Donnell R, Wilson BT, Sutton R</a><div class="gs_gray">C Leeson, HD Thomas, H Blair, S Fordham, J Lunec, J Allan, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=u3-iWPQAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=u3-iWPQAAAAJ:35r97b3x0nAC" class="gsc_a_at">Cancer Chemoprevention</a><div class="gs_gray">SC Clifford, DE Neal, J Lunec</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–332</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>